{"id":271,"date":"2021-08-09T16:57:52","date_gmt":"2021-08-09T16:57:52","guid":{"rendered":"https:\/\/crosettofoundation.org\/?p=271"},"modified":"2021-09-28T12:12:17","modified_gmt":"2021-09-28T12:12:17","slug":"intrigo-internazionale","status":"publish","type":"post","link":"https:\/\/crosettofoundation.org\/it\/intrigo-internazionale\/","title":{"rendered":"INTRIGO INTERNAZIONALE"},"content":{"rendered":"\t\t<div data-elementor-type=\"wp-post\" data-elementor-id=\"271\" class=\"elementor elementor-271 elementor-95\" data-elementor-post-type=\"post\">\n\t\t\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-2cef15e7 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"2cef15e7\" data-element_type=\"section\" data-e-type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-50b76a25\" data-id=\"50b76a25\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-23e06b82 elementor-widget elementor-widget-text-editor\" data-id=\"23e06b82\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p class=\"MsoNormal\" align=\"center\" style=\"margin-top:0in;margin-right:.65pt;\nmargin-bottom:0in;margin-left:1.0pt;text-align:center;line-height:normal\"><b><span style=\"font-size:14.0pt;font-family:\n&quot;Arial&quot;,sans-serif;color:black;mso-themecolor:text1;mso-font-width:110%;\nmso-ansi-language:IT\">I<span style=\"letter-spacing:-1.15pt\"> <\/span>20<span style=\"letter-spacing:-1.1pt\"> <\/span>miliardi<span style=\"letter-spacing:-1.1pt\">\n<\/span>annuali<span style=\"letter-spacing:-1.15pt\"> <\/span>spesi<span style=\"letter-spacing:-1.1pt\"> <\/span>per<span style=\"letter-spacing:-1.1pt\"> <\/span>il<span style=\"letter-spacing:-1.15pt\"> <\/span><span style=\"letter-spacing:-.15pt\">cancro<\/span><span style=\"letter-spacing:-1.1pt\"> <\/span>in<span style=\"letter-spacing:-1.1pt\"> <\/span>Italia\n<span style=\"letter-spacing:-.2pt\">non<\/span><span style=\"letter-spacing:-1.15pt\">\n<\/span><span style=\"letter-spacing:-.35pt\">devono <\/span>creare<span style=\"letter-spacing:-.65pt\"> <\/span><span style=\"letter-spacing:-.15pt\">una<\/span><span style=\"letter-spacing:-.6pt\"> <\/span><span style=\"letter-spacing:-.15pt\">competizione<\/span><span style=\"letter-spacing:-.65pt\"> <\/span><span style=\"letter-spacing:-.15pt\">tra<\/span><span style=\"letter-spacing:-.6pt\"> <\/span>i<span style=\"letter-spacing:-.6pt\"> <\/span><span style=\"letter-spacing:-.15pt\">ricercatori<\/span><span style=\"letter-spacing:\n-.65pt\"> <\/span><span style=\"letter-spacing:-.2pt\">ma<\/span><span style=\"letter-spacing:-.6pt\"> <\/span><span style=\"letter-spacing:-.15pt\">un\u2019unione\n<\/span><\/span><\/b><b><span style=\"font-size:14.0pt;font-family:&quot;Arial&quot;,sans-serif;color:black;mso-themecolor:\ntext1;mso-font-width:105%;mso-ansi-language:IT\">nel <span style=\"letter-spacing:\n-.15pt\">discutere <\/span><span style=\"letter-spacing:-.25pt\">pubblicamente <\/span>i\npiani strategici che possono <span style=\"letter-spacing:-.2pt\">sconfiggere <\/span>il\n<span style=\"letter-spacing:-.15pt\">nemico <\/span><span style=\"letter-spacing:\n-.2pt\">comune <\/span>che \u00e8 il<span style=\"letter-spacing:2.65pt\"> <\/span><span style=\"letter-spacing:-.15pt\">cancro<\/span><\/span><\/b><b><span style=\"font-size:14.0pt;font-family:&quot;Arial&quot;,sans-serif;\ncolor:black;mso-themecolor:text1;mso-ansi-language:IT\"><o:p><\/o:p><\/span><\/b><\/p><p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:.65pt;margin-bottom:0in;\nmargin-left:1.0pt;line-height:normal\"><b><span style=\"font-family:&quot;Times New Roman&quot;,serif;color:black;mso-themecolor:text1;\nmso-ansi-language:IT\">&nbsp;<\/span><\/b><\/p><p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\nmargin-left:1.0pt;line-height:normal\"><b><i><span style=\"font-family:&quot;Times New Roman&quot;,serif;\nmso-font-width:105%;mso-ansi-language:IT\">di ALESSANDRO TERRADURA<o:p><\/o:p><\/span><\/i><\/b><\/p><p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;\nmargin-left:1.0pt;line-height:normal\"><b><i><span style=\"font-family:&quot;Times New Roman&quot;,serif;\nmso-font-width:105%;mso-ansi-language:IT\">&nbsp;<\/span><\/i><\/b><\/p><p class=\"MsoBodyText\" style=\"text-indent:17.0pt\"><span style=\"font-size:11.0pt;\nfont-family:&quot;Times New Roman&quot;,serif\">C<span style=\"letter-spacing:-.25pt;\nmso-font-width:120%\">ontinuiamo<\/span><span style=\"letter-spacing:-1.8pt;\nmso-font-width:120%\">&nbsp; <\/span><span style=\"letter-spacing:-.3pt;mso-font-width:120%\">nell\u2019approfondimento <\/span><span style=\"letter-spacing:-.15pt;mso-font-width:115%\">di<\/span><span style=\"letter-spacing:-.9pt;mso-font-width:115%\"> <\/span><span style=\"letter-spacing:-.3pt;mso-font-width:115%\">questa<\/span><span style=\"letter-spacing:-.9pt;mso-font-width:115%\"> <\/span><span style=\"letter-spacing:-.25pt;mso-font-width:115%\">vicenda,<\/span><span style=\"letter-spacing:-.9pt;mso-font-width:115%\"> <\/span><span style=\"letter-spacing:-.2pt;mso-font-width:115%\">fino<\/span><span style=\"letter-spacing:-.85pt;mso-font-width:115%\"> <\/span><span style=\"letter-spacing:-.15pt;mso-font-width:115%\">ad<\/span><span style=\"letter-spacing:-.9pt;mso-font-width:115%\"> <\/span><span style=\"letter-spacing:-.25pt;mso-font-width:115%\">ora<\/span><span style=\"letter-spacing:-.9pt;mso-font-width:115%\"> <\/span><span style=\"letter-spacing:-.15pt;mso-font-width:115%\">la<\/span><span style=\"letter-spacing:-.85pt;mso-font-width:115%\"> <\/span><span style=\"letter-spacing:-.2pt;mso-font-width:115%\">ri<\/span><span style=\"letter-spacing:-.3pt;mso-font-width:115%\">costruzione<\/span><span style=\"letter-spacing:-1.4pt;mso-font-width:115%\"> <\/span><span style=\"letter-spacing:-.2pt;mso-font-width:115%\">non<\/span><span style=\"letter-spacing:-1.4pt;mso-font-width:115%\"> <\/span>\u00e8<span style=\"letter-spacing:-1.4pt\"> <\/span><span style=\"letter-spacing:-.35pt\">stata<\/span><span style=\"letter-spacing:-1.35pt\">\n<\/span><span style=\"letter-spacing:-.35pt\">contestata <\/span>proprio per un\ncriterio di massi<span style=\"letter-spacing:-.15pt\">ma <\/span><span style=\"letter-spacing:-.3pt\">responsabilit\u00e0 <\/span><span style=\"letter-spacing:\n-.2pt\">nei <\/span><span style=\"letter-spacing:-.25pt\">confronti <\/span><span style=\"letter-spacing:-.15pt\">di <\/span><span style=\"letter-spacing:-.25pt\">coloro\nche quotidianamente <\/span><span style=\"letter-spacing:-.3pt\">lottano <\/span><span style=\"letter-spacing:-.25pt\">con <\/span><span style=\"letter-spacing:-.3pt\">questo\n<\/span><span style=\"letter-spacing:-.25pt\">male bestiale. <o:p><\/o:p><\/span><\/span><\/p><p class=\"MsoBodyText\" style=\"text-indent:17.0pt\"><span style=\"font-size:11.0pt;\nfont-family:&quot;Times New Roman&quot;,serif;letter-spacing:-.2pt;mso-font-width:115%\">&nbsp;<\/span><\/p><p class=\"MsoBodyText\" style=\"text-indent:17.0pt\"><span style=\"font-size:11.0pt;\nfont-family:&quot;Times New Roman&quot;,serif;letter-spacing:-.2pt;mso-font-width:115%\">Diamo\n<\/span><span style=\"font-size:11.0pt;font-family:&quot;Times New Roman&quot;,serif;\nletter-spacing:-.25pt;mso-font-width:115%\">spazio <\/span><span style=\"font-size:11.0pt;font-family:&quot;Times New Roman&quot;,serif;letter-spacing:\n-.15pt;mso-font-width:115%\">ad <\/span><span style=\"font-size:11.0pt;font-family:\n&quot;Times New Roman&quot;,serif;letter-spacing:-.2pt;mso-font-width:115%\">una <\/span><span style=\"font-size:11.0pt;font-family:&quot;Times New Roman&quot;,serif;letter-spacing:\n-.25pt;mso-font-width:115%\">voce <\/span><span style=\"font-size:11.0pt;\nfont-family:&quot;Times New Roman&quot;,serif;letter-spacing:-.2pt;mso-font-width:115%\">fuori<\/span><span style=\"font-size:11.0pt;font-family:&quot;Times New Roman&quot;,serif;letter-spacing:\n-1.4pt;mso-font-width:115%\"> <\/span><span style=\"font-size:11.0pt;font-family:\n&quot;Times New Roman&quot;,serif;letter-spacing:-.25pt;mso-font-width:115%\">dal <\/span><span style=\"font-size:11.0pt;font-family:&quot;Times New Roman&quot;,serif;letter-spacing:\n-.3pt;mso-font-width:115%\">coro,<\/span><span style=\"font-size:11.0pt;\nfont-family:&quot;Times New Roman&quot;,serif;letter-spacing:-.55pt;mso-font-width:115%\">\n<\/span><span style=\"font-size:11.0pt;font-family:&quot;Times New Roman&quot;,serif;\nletter-spacing:-.25pt;mso-font-width:115%\">perch\u00e9<\/span><span style=\"font-size:\n11.0pt;font-family:&quot;Times New Roman&quot;,serif;letter-spacing:-.5pt;mso-font-width:\n115%\"> <\/span><span style=\"font-size:11.0pt;font-family:&quot;Times New Roman&quot;,serif;\nletter-spacing:-.15pt;mso-font-width:115%\">in<\/span><span style=\"font-size:\n11.0pt;font-family:&quot;Times New Roman&quot;,serif;letter-spacing:-.55pt;mso-font-width:\n115%\"> <\/span><span style=\"font-size:11.0pt;font-family:&quot;Times New Roman&quot;,serif;\nletter-spacing:-.3pt;mso-font-width:115%\">questa<\/span><span style=\"font-size:\n11.0pt;font-family:&quot;Times New Roman&quot;,serif;letter-spacing:-.5pt;mso-font-width:\n115%\"> <\/span><span style=\"font-size:11.0pt;font-family:&quot;Times New Roman&quot;,serif;\nletter-spacing:-.3pt;mso-font-width:115%\">battaglia<\/span><span style=\"font-size:11.0pt;font-family:&quot;Times New Roman&quot;,serif;letter-spacing:\n-.5pt;mso-font-width:115%\"> <\/span><span style=\"font-size:11.0pt;font-family:\n&quot;Times New Roman&quot;,serif;letter-spacing:-.2pt;mso-font-width:115%\">nulla<\/span><span style=\"font-size:11.0pt;font-family:&quot;Times New Roman&quot;,serif;letter-spacing:\n-.55pt;mso-font-width:115%\"> <\/span><span style=\"font-size:11.0pt;font-family:\n&quot;Times New Roman&quot;,serif;letter-spacing:-.2pt;mso-font-width:115%\">deve<\/span><span style=\"font-size:11.0pt;font-family:&quot;Times New Roman&quot;,serif;letter-spacing:\n-.5pt;mso-font-width:115%\"> <\/span><span style=\"font-size:11.0pt;font-family:\n&quot;Times New Roman&quot;,serif;letter-spacing:-.2pt;mso-font-width:115%\">ri<\/span><span style=\"font-size:11.0pt;font-family:&quot;Times New Roman&quot;,serif;letter-spacing:\n-.25pt;mso-font-width:115%\">manere<\/span><span style=\"font-size:11.0pt;\nfont-family:&quot;Times New Roman&quot;,serif;letter-spacing:-1.25pt;mso-font-width:115%\">\n<\/span><span style=\"font-size:11.0pt;font-family:&quot;Times New Roman&quot;,serif;\nletter-spacing:-.3pt;mso-font-width:115%\">intentato,<\/span><span style=\"font-size:11.0pt;font-family:&quot;Times New Roman&quot;,serif;letter-spacing:\n-1.25pt;mso-font-width:115%\"> <\/span><span style=\"font-size:11.0pt;font-family:\n&quot;Times New Roman&quot;,serif;mso-font-width:115%\">e<span style=\"letter-spacing:-1.25pt\">\n<\/span><span style=\"letter-spacing:-.2pt\">siamo<\/span><span style=\"letter-spacing:\n-1.25pt\"> <\/span><span style=\"letter-spacing:-.25pt\">aperti<\/span><span style=\"letter-spacing:-1.25pt\"> <\/span>e<span style=\"letter-spacing:-1.25pt\"> <\/span><span style=\"letter-spacing:-.2pt\">diamo<\/span><span style=\"letter-spacing:-1.25pt\"> <\/span><span style=\"letter-spacing:-.25pt\">spazio,<\/span><span style=\"letter-spacing:-.7pt\">\n<\/span><span style=\"letter-spacing:-.25pt\">verificandone<\/span><span style=\"letter-spacing:-.65pt\"> <\/span>i<span style=\"letter-spacing:-.65pt\"> <\/span><span style=\"letter-spacing:-.3pt\">presupposti,<\/span><span style=\"letter-spacing:\n-.65pt\"> <\/span><span style=\"letter-spacing:-.15pt\">ad<\/span><span style=\"letter-spacing:-.65pt\"> <\/span><span style=\"letter-spacing:-.2pt\">ogni<\/span><span style=\"letter-spacing:-.65pt\"> <\/span><span style=\"letter-spacing:-.25pt\">voce\nnuova <\/span><span style=\"letter-spacing:-.2pt\">che possa <\/span><span style=\"letter-spacing:-.25pt\">contribuire <\/span><span style=\"letter-spacing:\n-.2pt\">alla <\/span><span style=\"letter-spacing:-.35pt\">lotta <\/span><span style=\"letter-spacing:-.25pt\">contro <\/span><span style=\"letter-spacing:-.15pt\">il<\/span><span style=\"letter-spacing:-1.1pt\"> <\/span><span style=\"letter-spacing:-.3pt\">cancro.<\/span><\/span><span style=\"font-size:11.0pt;font-family:&quot;Times New Roman&quot;,serif\"><o:p><\/o:p><\/span><\/p><p class=\"MsoBodyText\" style=\"text-indent:17.0pt\"><span style=\"font-size:11.0pt;\nfont-family:&quot;Times New Roman&quot;,serif\">&nbsp;<\/span><\/p><p class=\"MsoBodyText\" style=\"text-indent:17.0pt\"><span style=\"font-size:11.0pt;\nfont-family:&quot;Times New Roman&quot;,serif;letter-spacing:-.25pt;mso-font-width:115%\">Riprendiamo\n<\/span><span style=\"font-size:11.0pt;font-family:&quot;Times New Roman&quot;,serif;\nmso-font-width:115%\">a<span style=\"letter-spacing:-1.85pt\"> <\/span><span style=\"letter-spacing:-.3pt\">fare <\/span><span style=\"letter-spacing:-.25pt\">domande\n<\/span><span style=\"letter-spacing:-.15pt\">al <\/span><span style=\"letter-spacing:\n-.25pt\">dott. <\/span><span style=\"letter-spacing:-.3pt\">Croset<\/span><span style=\"letter-spacing:-.2pt\">to <\/span><span style=\"letter-spacing:-.3pt\">facendo\n<\/span><span style=\"letter-spacing:-.25pt\">riferimento <\/span><span style=\"letter-spacing:-.2pt\">agli <\/span><span style=\"letter-spacing:-.25pt\">articoli\n<\/span><span style=\"letter-spacing:-.3pt\">pubblicati <\/span><span style=\"letter-spacing:-.15pt\">su <\/span><span style=\"letter-spacing:-.2pt\">\u201cIl <\/span><span style=\"letter-spacing:-.25pt\">Previdente\u201d <\/span><span style=\"letter-spacing:\n-.15pt\">di <\/span><span style=\"letter-spacing:-.25pt\">novembre <\/span>e <span style=\"letter-spacing:-.25pt\">dicembre <\/span><span style=\"letter-spacing:-.2pt\">2020,\nanche <\/span><span style=\"letter-spacing:-.25pt\">disponibili <\/span>a <\/span><span style=\"font-size:11.0pt;font-family:&quot;Times New Roman&quot;,serif\">http:\/\/bit.ly\/<\/span><a href=\"https:\/\/drive.google.com\/file\/d\/1CVGoAp8YnJtGugQfFBDOUjjHHJIfFbSg\/view?usp=sharing\"><span style=\"font-size:11.0pt;font-family:&quot;Times New Roman&quot;,serif\">3okv90L<\/span><\/a><span style=\"font-size:11.0pt;font-family:&quot;Times New Roman&quot;,serif;letter-spacing:\n-.2pt;mso-font-width:115%\">) (<\/span><span style=\"font-size:11.0pt;font-family:\n&quot;Times New Roman&quot;,serif\">http:\/\/bit.ly\/<\/span><a href=\"https:\/\/drive.google.com\/file\/d\/1e4orusgrn5dNEuvPmqQ_TDBvmJNm_7Mn\/view?usp=sharing\"><span style=\"font-size:11.0pt;font-family:&quot;Times New Roman&quot;,serif\">3nQjpTS<\/span><\/a><span style=\"font-size:11.0pt;font-family:&quot;Times New Roman&quot;,serif;letter-spacing:\n-.3pt;mso-font-width:115%\">) <\/span><span style=\"font-size:11.0pt;font-family:\n&quot;Times New Roman&quot;,serif;letter-spacing:-.15pt;mso-font-width:115%\">ed <\/span><span style=\"font-size:11.0pt;font-family:&quot;Times New Roman&quot;,serif;letter-spacing:\n-.2pt;mso-font-width:115%\">alla <\/span><span style=\"font-size:11.0pt;\nfont-family:&quot;Times New Roman&quot;,serif;letter-spacing:-.3pt;mso-font-width:115%\">pagina\nFacebook<\/span><span style=\"font-size:11.0pt;font-family:&quot;Times New Roman&quot;,serif;\nletter-spacing:-1.5pt;mso-font-width:115%\"> <\/span><span style=\"font-size:11.0pt;\nfont-family:&quot;Times New Roman&quot;,serif;letter-spacing:-.15pt;mso-font-width:115%\">di<\/span><span style=\"font-size:11.0pt;font-family:&quot;Times New Roman&quot;,serif;letter-spacing:\n-1.5pt;mso-font-width:115%\"> <\/span><span style=\"font-size:11.0pt;font-family:\n&quot;Times New Roman&quot;,serif;letter-spacing:-.25pt;mso-font-width:115%\">United<\/span><span style=\"font-size:11.0pt;font-family:&quot;Times New Roman&quot;,serif;letter-spacing:\n-1.5pt;mso-font-width:115%\"> <\/span><span style=\"font-size:11.0pt;font-family:\n&quot;Times New Roman&quot;,serif;letter-spacing:-.45pt;mso-font-width:115%\">To<\/span><span style=\"font-size:11.0pt;font-family:&quot;Times New Roman&quot;,serif;letter-spacing:\n-1.5pt;mso-font-width:115%\"> <\/span><span style=\"font-size:11.0pt;font-family:\n&quot;Times New Roman&quot;,serif;letter-spacing:-.2pt;mso-font-width:115%\">End<\/span><span style=\"font-size:11.0pt;font-family:&quot;Times New Roman&quot;,serif;letter-spacing:\n-1.45pt;mso-font-width:115%\"> <\/span><span style=\"font-size:11.0pt;font-family:\n&quot;Times New Roman&quot;,serif;letter-spacing:-.25pt;mso-font-width:115%\">Cancer<\/span><span style=\"font-size:11.0pt;font-family:&quot;Times New Roman&quot;,serif;letter-spacing:\n-1.5pt;mso-font-width:115%\"> <\/span><span style=\"font-size:11.0pt;font-family:\n&quot;Times New Roman&quot;,serif;letter-spacing:-.25pt;mso-font-width:115%\">(<\/span><span style=\"font-size:11.0pt;font-family:&quot;Times New Roman&quot;,serif\">https:\/\/bit.ly\/<\/span><a href=\"https:\/\/www.facebook.com\/United-to-End-Cancer-114803041888974\"><span style=\"font-size:11.0pt;font-family:&quot;Times New Roman&quot;,serif\">348Yrru<\/span><\/a><span style=\"font-size:11.0pt;font-family:&quot;Times New Roman&quot;,serif;letter-spacing:\n-.3pt;mso-font-width:115%\">)<\/span><span style=\"font-size:11.0pt;font-family:\n&quot;Times New Roman&quot;,serif;letter-spacing:-1.3pt;mso-font-width:115%\"> <\/span><span style=\"font-size:11.0pt;font-family:&quot;Times New Roman&quot;,serif;letter-spacing:\n-.2pt;mso-font-width:115%\">per<\/span><span style=\"font-size:11.0pt;font-family:\n&quot;Times New Roman&quot;,serif;letter-spacing:-1.25pt;mso-font-width:115%\"> <\/span><span style=\"font-size:11.0pt;font-family:&quot;Times New Roman&quot;,serif;letter-spacing:\n-.3pt;mso-font-width:115%\">accedere<\/span><span style=\"font-size:11.0pt;\nfont-family:&quot;Times New Roman&quot;,serif;letter-spacing:-1.3pt;mso-font-width:115%\">\n<\/span><span style=\"font-size:11.0pt;font-family:&quot;Times New Roman&quot;,serif;\nmso-font-width:115%\">a<span style=\"letter-spacing:-1.25pt\"> <\/span><span style=\"letter-spacing:-.25pt\">numerosi<\/span><span style=\"letter-spacing:-1.25pt\">\n<\/span><span style=\"letter-spacing:-.25pt\">articoli<\/span><span style=\"letter-spacing:-1.3pt\"> <\/span><span style=\"letter-spacing:-.25pt\">in\ninglese<\/span><span style=\"letter-spacing:-.65pt\"> <\/span>e<span style=\"letter-spacing:-.6pt\"> <\/span><span style=\"letter-spacing:-.3pt\">italiano,<\/span><span style=\"letter-spacing:-.6pt\"> <\/span><span style=\"letter-spacing:-.25pt\">nonch\u00e9<\/span><span style=\"letter-spacing:-.6pt\"> <\/span>i<span style=\"letter-spacing:-.6pt\"> <\/span><span style=\"letter-spacing:-.3pt\">contatti<\/span><span style=\"letter-spacing:-.6pt\">\n<\/span><span style=\"letter-spacing:-.2pt\">della<\/span><span style=\"letter-spacing:\n-.6pt\"> <\/span><span style=\"letter-spacing:-.25pt\">Fondazione <\/span><span style=\"letter-spacing:-.2pt\">che <\/span><span style=\"letter-spacing:-.25pt\">risulta\ntra <\/span><span style=\"letter-spacing:-.15pt\">le <\/span><span style=\"letter-spacing:-.25pt\">no-profit degli <\/span><span style=\"letter-spacing:\n-.35pt\">Stati <\/span><span style=\"letter-spacing:-.2pt\">Uniti che, per <\/span><span style=\"letter-spacing:-.25pt\">legge, <\/span><span style=\"letter-spacing:-.2pt\">devono\n<\/span><span style=\"letter-spacing:-.25pt\">pubblicare gli introiti<\/span><span style=\"letter-spacing:-.95pt\"> <\/span>e<span style=\"letter-spacing:-.95pt\"> <\/span><span style=\"letter-spacing:-.15pt\">le<\/span><span style=\"letter-spacing:-.95pt\"> <\/span><span style=\"letter-spacing:-.25pt\">dichiarazioni<\/span><span style=\"letter-spacing:\n-.95pt\"> <\/span><span style=\"letter-spacing:-.2pt\">delle<\/span><span style=\"letter-spacing:-.95pt\"> <\/span><span style=\"letter-spacing:-.25pt\">tasse<\/span><span style=\"letter-spacing:-.95pt\"> <\/span><span style=\"letter-spacing:-.25pt\">raggiungi<\/span><span style=\"letter-spacing:-.2pt\">bili<\/span><span style=\"letter-spacing:-1.25pt\"> <\/span><span style=\"letter-spacing:-.15pt\">al<\/span><span style=\"letter-spacing:-1.2pt\"> <\/span><span style=\"letter-spacing:-.25pt\">sito<\/span><span style=\"letter-spacing:-1.2pt\"> <\/span><span style=\"letter-spacing:-.15pt\">di<\/span><span style=\"letter-spacing:-1.2pt\"> <\/span><span style=\"letter-spacing:-.3pt\">GuideStar<\/span><span style=\"letter-spacing:-1.25pt\">\n<\/span><span style=\"letter-spacing:-.3pt\">(<\/span><\/span><a href=\"https:\/\/www.guidestar.org\/profile\/03-0544575\"><span style=\"font-size:\n11.0pt;font-family:&quot;Times New Roman&quot;,serif;letter-spacing:-.3pt;mso-font-width:\n115%\">https:\/\/www.guidestar.<\/span><\/a><a href=\"https:\/\/www.guidestar.org\/profile\/03-0544575\"><span style=\"font-size:\n11.0pt;font-family:&quot;Times New Roman&quot;,serif;letter-spacing:-.25pt;mso-font-width:\n115%\">org\/profile\/03-0544575<\/span><\/a><span style=\"font-size:11.0pt;\nfont-family:&quot;Times New Roman&quot;,serif;letter-spacing:-.25pt;mso-font-width:115%\">).<\/span><span style=\"font-size:11.0pt;font-family:&quot;Times New Roman&quot;,serif\"><o:p><\/o:p><\/span><\/p><p class=\"yiv6440921889msonormal\" style=\"margin-top:0in;margin-right:0in;\nmargin-bottom:0in;margin-left:1.0pt;text-align:justify;text-indent:17.0pt\"><b><span style=\"font-family:&quot;Times New Roman&quot;,serif;color:black;mso-themecolor:text1\">&nbsp;<\/span><\/b><\/p><p class=\"yiv6440921889msonormal\" style=\"margin-top:0in;margin-right:0in;\nmargin-bottom:0in;margin-left:1.0pt;text-align:justify;text-indent:17.0pt\"><b><span style=\"font-family:&quot;Times New Roman&quot;,serif;color:black;mso-themecolor:text1\">&nbsp;<\/span><\/b><\/p><p class=\"yiv6440921889msonormal\" style=\"margin-top:0in;margin-right:0in;\nmargin-bottom:0in;margin-left:1.0pt;text-align:justify;text-indent:-1.0pt\"><b><span style=\"font-size:12.0pt;font-family:&quot;Arial&quot;,sans-serif;color:black;mso-themecolor:\ntext1\">Ci siamo incontrati diverse volte e di lei abbiamo scritto riguardo alla\nsua creatura il 3D-CBS, ma chi \u00e8 Dario Crosetto, uno scienziato, un luminare,\nun sognatore che con la sua invenzione lotta contro i mulini a vento, ce lo\nspieghi lei.&nbsp;<\/span><\/b><span style=\"font-size:12.0pt;font-family:&quot;Arial&quot;,sans-serif;\ncolor:black;mso-themecolor:text1\"><o:p><\/o:p><\/span><\/p><p class=\"yiv6440921889msonormal\" style=\"margin-top:0in;margin-right:0in;\nmargin-bottom:0in;margin-left:1.0pt;text-align:justify;text-indent:17.0pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif;color:black;mso-themecolor:text1\">&nbsp;<\/span><\/p><p class=\"yiv6440921889msonormal\" style=\"margin-top:0in;margin-right:0in;\nmargin-bottom:0in;margin-left:1.0pt;text-align:justify;text-indent:17.0pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif;color:black;mso-themecolor:text1\">Le\nmie affermazioni si sono rivelate e continuano a&nbsp; rivelarsi corrette anno\ndopo anno, mentre milioni di vite vengono perse inutilmente perch\u00e9 la\ntrasparenza e le procedure scientifiche che affrontano le mie invenzioni\ncontinuano ad essere soppresse (<b>oltre 20 milioni di vite sono state perse\ninutilmente nel mondo e oltre 1,2 milioni di vite sono state perse inutilmente\nin ITALIA dalla mia invenzione 3D-CBS del 2000<\/b>) perch\u00e9 scienziati,\ngiornalisti e media non vogliono esprimere ci\u00f2 su cui non sono eventualmente\nd&#8217;accordo circa il mio piano strategico (<\/span><span style=\"font-family:&quot;Times New Roman&quot;,serif;\ncolor:blue\">https:\/\/<\/span><a href=\"https:\/\/drive.google.com\/file\/d\/1-S9SlV86kzE0nHV_gLvYpqA5wDxgYJua\/view?usp=sharing\" target=\"_blank\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">bit.ly\/3jT1edb<\/span><\/a><span style=\"font-family:&quot;Times New Roman&quot;,serif;color:black;mso-themecolor:text1\">)\ne&nbsp;<b>non vogliono testare su una popolazione campione quante vite pu\u00f2\nsalvare ogni anno il dispositivo EXPLORER gi\u00e0 esistente<\/b>&nbsp;(meno\nefficiente, ma fondamentalmente copiato dalla mia invenzione)&nbsp;<b>e quindi\nutilizzare il mio dispositivo 3D-CBS<\/b>&nbsp;(Esame Completo del Corpo in\n3-D)&nbsp;<b>per una comparazione<\/b>.<o:p><\/o:p><\/span><\/p><p class=\"yiv6440921889msonormal\" style=\"margin-top:0in;margin-right:0in;\nmargin-bottom:0in;margin-left:1.0pt;text-align:justify;text-indent:17.0pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif;color:black;mso-themecolor:text1\">&nbsp;<\/span><\/p><p class=\"yiv6440921889msonormal\" style=\"margin-top:0in;margin-right:0in;\nmargin-bottom:0in;margin-left:1.0pt;text-align:justify;text-indent:17.0pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif;color:black;mso-themecolor:text1\">Ho\nlavorato e progettato la strumentazione avanzata per i pi\u00f9 grandi esperimenti\npresso i principali laboratori di Ricerca del mondo: CERN, Superconducting\nSuper Collider -SSC-, FERMILab, Brookhaven National Laboratory, ecc. (Bio di\n2-pagine&nbsp;<\/span><a href=\"https:\/\/drive.google.com\/file\/d\/0BxWfo2ViJ6r5dmFIYVRsR1NBSnc\/view?usp=sharing\" target=\"_blank\"><span style=\"font-family:&quot;Times New Roman&quot;,serif;background:\n#EEEEEE\">goo.gl\/XQ3JyY<\/span><\/a><span style=\"font-family:&quot;Times New Roman&quot;,serif;\ncolor:black;mso-themecolor:text1\">&nbsp;e testimonianze&nbsp;<\/span><a href=\"https:\/\/goo.gl\/VXBx33\" target=\"_blank\"><span style=\"font-family:&quot;Times New Roman&quot;,serif;\nbackground:#EEEEEE\">goo.gl\/VXBx33<\/span><\/a><span style=\"font-family:&quot;Times New Roman&quot;,serif;\ncolor:black;mso-themecolor:text1\">).<o:p><\/o:p><\/span><\/p><p class=\"yiv6440921889msonormal\" style=\"margin-top:0in;margin-right:0in;\nmargin-bottom:0in;margin-left:1.0pt;text-align:justify;text-indent:17.0pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif;color:black;mso-themecolor:text1\">&nbsp;<\/span><\/p><p class=\"yiv6440921889ydpe751daa4yiv1826162349msonormal\" style=\"margin-top:0in;\nmargin-right:0in;margin-bottom:0in;margin-left:1.0pt;text-align:justify;\ntext-indent:17.0pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif;\ncolor:black;mso-themecolor:text1\">Sono stato assunto prima al CERN di Ginevra e\ndal 1991 all&#8217; SSC in Texas. Ho tenuto seminari nelle pi\u00f9 prestigiose Universit\u00e0\ne centri di ricerca del mondo (Germania, Francia, Belgio, Stati Uniti, Canada,\nGiappone, Columbia, Messico, Argentina, Ghana, SriLanka e Cina) e presso i\nmigliori Ospedali universitari e Centri di Ricerca sul cancro in Italia e a\nGinevra, in Svizzera, e scritto cinque libri e oltre 100 articoli, riportando\ninvenzioni supportate da calcoli e rivendicazioni dimostrate fattibili e\nfunzionanti che creano un cambiamento paradigmatico nel settore del\nriconoscimento di oggetti in applicazioni in tempo reale ad altissima velocit\u00e0,\nnel rilevamento di particelle e nella diagnostica medica.<o:p><\/o:p><\/span><\/p><p class=\"yiv6440921889ydpe751daa4yiv1826162349msonormal\" style=\"margin-top:0in;\nmargin-right:0in;margin-bottom:0in;margin-left:1.0pt;text-align:justify;\ntext-indent:17.0pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif;\ncolor:black;mso-themecolor:text1\">&nbsp;<\/span><\/p><p class=\"yiv6440921889ydpe751daa4yiv1826162349msonormal\" style=\"margin-top:0in;\nmargin-right:0in;margin-bottom:0in;margin-left:1.0pt;text-align:justify;\ntext-indent:17.0pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif;\ncolor:black;mso-themecolor:text1\">Ho dimostrato come sia funzionante in\ncircuiti hardware la prova di concetto della mia invenzione confermandone i\nsuoi vantaggi, ma il finanziamento per un sistema completo \u00e8 andato ad approcci\nmeno efficienti e pi\u00f9 costosi a causa della mancanza di responsabilit\u00e0 nei\nconfronti dei soldi dei contribuenti e delle donazioni.<o:p><\/o:p><\/span><\/p><p class=\"yiv6440921889ydpe751daa4yiv1826162349msonormal\" style=\"margin-top:0in;\nmargin-right:0in;margin-bottom:0in;margin-left:1.0pt;text-align:justify;\ntext-indent:17.0pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif;\ncolor:black;mso-themecolor:text1\">&nbsp;<\/span><\/p><p class=\"yiv6440921889ydpe751daa4yiv1826162349msonormal\" style=\"margin-top:0in;\nmargin-right:0in;margin-bottom:0in;margin-left:1.0pt;text-align:justify;\ntext-indent:17.0pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif;\ncolor:black;mso-themecolor:text1\">Ho ricevuto 1 milione di dollari in borse di\nricerca dal Governo Americano. Avevo diritto al 20% di 1 milione come stipendio\ntotale durante l&#8217;intero periodo della borsa di ricerca, invece ho usato la\nmaggior parte di questi soldi per acquistare componenti elettronici al fine di\navanzare nella ricerca.<o:p><\/o:p><\/span><\/p><p class=\"yiv6440921889ydpe751daa4yiv1826162349msonormal\" style=\"margin-top:0in;\nmargin-right:0in;margin-bottom:0in;margin-left:1.0pt;text-align:justify;\ntext-indent:17.0pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif;\ncolor:black;mso-themecolor:text1\">&nbsp;<\/span><\/p><p class=\"yiv6440921889ydpe751daa4yiv1826162349msonormal\" style=\"margin-top:0in;\nmargin-right:0in;margin-bottom:0in;margin-left:1.0pt;text-align:justify;\ntext-indent:17.0pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif;\ncolor:black;mso-themecolor:text1\">Con il restante 80%, ho assunto 4 giovani e\npagato i migliori consulenti professionisti del settore come la Synopsys e ho\nriportato i miei risultati in un articolo di 45 pagine approvato formalmente in\nuna revisione paritaria e pubblicato su una delle riviste scientifiche pi\u00f9\nprestigiose (<\/span><a href=\"https:\/\/drive.google.com\/file\/d\/0BxWfo2ViJ6r5NlVSWHhoTl9jZXc\/view?usp=sharing\" target=\"_blank\"><span style=\"font-family:&quot;Times New Roman&quot;,serif;background:\n#EEEEEE\">goo.gl\/bqhD4R<\/span><\/a><span style=\"font-family:&quot;Times New Roman&quot;,serif;\ncolor:black;mso-themecolor:text1\">).<o:p><\/o:p><\/span><\/p><p class=\"yiv6440921889ydpe751daa4yiv1826162349msonormal\" style=\"margin-top:0in;\nmargin-right:0in;margin-bottom:0in;margin-left:1.0pt;text-align:justify;\ntext-indent:17.0pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif;\ncolor:black;mso-themecolor:text1\">&nbsp;<\/span><\/p><p class=\"yiv6440921889ydpe751daa4yiv1826162349msolistparagraph\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;margin-left:1.0pt;\ntext-align:justify;text-indent:17.0pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif;\ncolor:black;mso-themecolor:text1\">Ho continuato a lavorare gratuitamente per 20\nanni mettendo concretamente gli altri al primo posto usando tutti i fondi\nricevuti in donazione per gli altri per avanzare nella ricerca.<o:p><\/o:p><\/span><\/p><p class=\"yiv6440921889msonormal\" style=\"margin:0in;text-align:justify\"><span style=\"font-family:&quot;Times New Roman&quot;,serif;color:black;mso-themecolor:text1\">&nbsp;<o:p><\/o:p><\/span><\/p><p class=\"yiv6440921889msonormal\" style=\"margin:0in;text-align:justify\"><span style=\"font-family:&quot;Times New Roman&quot;,serif;color:black;mso-themecolor:text1\">&nbsp;<\/span><\/p><p class=\"yiv6440921889msonormal\" style=\"margin:0in;text-align:justify\"><b><span style=\"font-size:12.0pt;font-family:&quot;Arial&quot;,sans-serif;color:black;mso-themecolor:\ntext1\">Ci pu\u00f2 riassumere come \u00e8 nata l\u2019idea e quali sono le potenzialit\u00e0 del\n3D-CBS?<\/span><\/b><span style=\"font-size:12.0pt;font-family:&quot;Arial&quot;,sans-serif;\ncolor:black;mso-themecolor:text1\"><o:p><\/o:p><\/span><\/p><p class=\"yiv6440921889msonormal\" style=\"margin:0in;text-align:justify;\ntext-indent:.25in\"><span style=\"font-family:&quot;Times New Roman&quot;,serif;color:black;\nmso-themecolor:text1\">&nbsp;<\/span><\/p><p class=\"yiv6440921889msonormal\" style=\"margin:0in;text-align:justify;\ntext-indent:.25in\"><span style=\"font-family:&quot;Times New Roman&quot;,serif;color:black;\nmso-themecolor:text1\">Bisogna risalire all\u2019invenzione 3D-Flow che supera i\nlimiti nel riconoscere oggetti dall\u2019analisi di dati in arrivo da migliaia di\ncanali elettronici ad altissima velocit\u00e0 che avevo inventato per scoprire nuove\nparticelle subatomiche negli esperimenti dei centri di ricerca pi\u00f9 importanti\nal mondo del CERN di Ginevra e dell\u2019SSC in Texas. <o:p><\/o:p><\/span><\/p><p class=\"yiv6440921889msonormal\" style=\"margin:0in;text-align:justify;\ntext-indent:.25in\"><span style=\"font-family:&quot;Times New Roman&quot;,serif;color:black;\nmso-themecolor:text1\">&nbsp;<\/span><\/p><p class=\"yiv6440921889msonormal\" style=\"margin:0in;text-align:justify;\ntext-indent:.25in\"><span style=\"font-family:&quot;Times New Roman&quot;,serif;color:black;\nmso-themecolor:text1\">Il merito scientifico dell\u2019invenzione 3D-Flow \u00e8 stato\nriconosciuto ufficialmente nel 1993 in una revisione scientifica pubblica\ninternazionale (<\/span><a href=\"https:\/\/drive.google.com\/file\/d\/0BxWfo2ViJ6r5amx4ZlN2OTJqMmM\/view?usp=sharing\"><span style=\"font-family: &quot;Times New Roman&quot;, serif; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\">goo.gl\/zP76Tc<\/span><\/a><span style=\"font-family:&quot;Times New Roman&quot;,serif;color:black;mso-themecolor:text1\">)\ndella massima importanza tenutasi presso il FERMILab di Chicago che era stata\nrichiesta dal Direttore dell\u2019SSC, anche Direttore del Fermilab. <o:p><\/o:p><\/span><\/p><p class=\"yiv6440921889msonormal\" style=\"margin:0in;text-align:justify;\ntext-indent:.25in\"><span style=\"font-family:&quot;Times New Roman&quot;,serif;color:black;\nmso-themecolor:text1\">&nbsp;<\/span><\/p><p class=\"yiv6440921889msonormal\" style=\"margin:0in;text-align:justify;\ntext-indent:.25in\"><span style=\"font-family:&quot;Times New Roman&quot;,serif;color:black;\nmso-themecolor:text1\">Il 3D-Flow \u00e8 stato adottato da migliaia di scienziati\ndell\u2019esperimento di mezzo miliardo di dollari GEM all\u2019SSC. Tuttavia, il\nCongresso Americano tramite il Dipartimento dell\u2019Energia degli USA ha\ncancellato l\u2019intero progetto SSC da 11 miliardi di dollari che comprendeva\nanche il rivelatore GEM. <o:p><\/o:p><\/span><\/p><p class=\"yiv6440921889msonormal\" style=\"margin:0in;text-align:justify;\ntext-indent:.25in\"><span style=\"font-family:&quot;Times New Roman&quot;,serif;color:black;\nmso-themecolor:text1\">&nbsp;<\/span><\/p><p class=\"yiv6440921889msonormal\" style=\"margin:0in;text-align:justify;\ntext-indent:.25in\"><span style=\"font-family:&quot;Times New Roman&quot;,serif;color:black;\nmso-themecolor:text1\">Nel 1995 la mia invenzione 3D-Flow \u00e8 stata adottata da\ncentinaia di scienziati dell\u2019esperimento LHCb al CERN di Ginevra. Tuttavia, nel\n1999 il Dipartimento dell\u2019Energia degli USA ha tagliato tutti i fondi agli\nesperimenti LHCb e ALICE al CERN. <o:p><\/o:p><\/span><\/p><p class=\"yiv6440921889msonormal\" style=\"margin:0in;text-align:justify;\ntext-indent:.25in\"><span style=\"font-family:&quot;Times New Roman&quot;,serif;color:black;\nmso-themecolor:text1\">&nbsp;<\/span><\/p><p class=\"yiv6440921889msonormal\" style=\"margin:0in;text-align:justify;\ntext-indent:.25in\"><span style=\"font-family:&quot;Times New Roman&quot;,serif;color:black;\nmso-themecolor:text1\">La mia invenzione 3D-Flow \u00e8 stata sostituita da un\ndispositivo pi\u00f9 costoso, di vecchia concezione, meno efficiente perch\u00e9 i fondi\nper la ricerca, come riporta l\u2019articolo sul Scientific American di Ottobre 2018\n(<\/span><span style=\"font-family:&quot;Times New Roman&quot;,serif;color:blue\">https:\/\/bit.ly\/<\/span><a href=\"https:\/\/www.scientificamerican.com\/article\/science-funding-is-broken\/\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">369yNDZ<\/span><\/a><span style=\"font-family:&quot;Times New Roman&quot;,serif;color:black;mso-themecolor:text1\">)\nnon vanno ai progetti migliori, ma ai ricercatori che hanno i migliori\ncollegamenti. <o:p><\/o:p><\/span><\/p><p class=\"yiv6440921889msonormal\" style=\"margin:0in;text-align:justify;\ntext-indent:.25in\"><span style=\"font-family:&quot;Times New Roman&quot;,serif;color:black;\nmso-themecolor:text1\">&nbsp;<\/span><\/p><p class=\"yiv6440921889msonormal\" style=\"margin:0in;text-align:justify;\ntext-indent:.25in\"><span style=\"font-family:&quot;Times New Roman&quot;,serif;color:black;\nmso-themecolor:text1\">Trovandomi per la seconda volta la strada realizzativa\ndella mia invenzione interrotta per motivi politici e\/o per sfortuna ed anche\nperch\u00e9 il ritorno in benefici all\u2019umanit\u00e0 dalle scoperte in fisica delle\nparticelle \u00e8 tipicamente di 35-40 anni, <b>mi sono domandato se potevo\ncontribuire alla soluzione dei problemi pi\u00f9 gravi per l\u2019umanit\u00e0 con un ritorno\nin benefici dopo 2-5 anni anzich\u00e9 35-40 anni<\/b>. <o:p><\/o:p><\/span><\/p><p class=\"yiv6440921889msonormal\" style=\"margin:0in;text-align:justify;\ntext-indent:.25in\"><span style=\"font-family:&quot;Times New Roman&quot;,serif;color:black;\nmso-themecolor:text1\">&nbsp;<\/span><\/p><p class=\"yiv6440921889msonormal\" style=\"margin-top:0in;margin-right:14.8pt;\nmargin-bottom:0in;margin-left:13.5pt;text-align:justify\"><b><i><span style=\"font-size:12.0pt;font-family:&quot;Times New Roman&quot;,serif;color:black;\nmso-themecolor:text1\">\u201cHo quindi analizzato che il problema pi\u00f9 mortale e\ncostoso al mondo \u00e8 il cancro. Mi sono reso conto dallo studio di dati\nsperimentali che la diagnosi precoce pu\u00f2 salvare la vita fino al 98% dei malati\ndi cancro e mi sono quindi domandato se era possibile progettare uno strumento\nefficace e dal costo vantaggioso per la diagnosi precoce della maggior parte\ndei tumori presenti in tutto il corpo\u201d<\/span><\/i><\/b><b><span style=\"font-family:\n&quot;Times New Roman&quot;,serif;color:black;mso-themecolor:text1\">.<o:p><\/o:p><\/span><\/b><\/p><p class=\"yiv6440921889msonormal\" style=\"margin:0in;text-align:justify;\ntext-indent:.25in\"><b><span style=\"font-family:&quot;Times New Roman&quot;,serif;\ncolor:black;mso-themecolor:text1\">&nbsp;<\/span><\/b><\/p><p class=\"yiv6440921889msonormal\" style=\"margin:0in;text-align:justify;\ntext-indent:.25in\"><span style=\"font-family:&quot;Times New Roman&quot;,serif;color:black;\nmso-themecolor:text1\">Dal gennaio 2000, ho quindi trascorso cinque mesi nella\nbiblioteca del maggiore ospedale universitario di Dallas UT Southwestern\nMedical Center per studiare tutte le principali apparecchiature diagnostiche.\nNe ho trovate di due tipi: quelle che misurano e visualizzano la densit\u00e0 dei\ntessuti (Raggi-X, Risonanza Magnetica, Mammografia, Ultrasuoni, TAC, ecc. e\nquelle della Medicina Nucleare che misurano e visualizzano i processi biologici\nanomali prima ancora che avvenga un cambiamento morfologico (Scintigrafia e\nPET). La scintigrafia \u00e8 molto inefficiente e cattura circa un segnale su\n300.000 mentre la PET del 2000 cattura circa un segnale su 10.000. <o:p><\/o:p><\/span><\/p><p class=\"yiv6440921889msonormal\" style=\"margin:0in;text-align:justify;\ntext-indent:.25in\"><span style=\"font-family:&quot;Times New Roman&quot;,serif;color:black;\nmso-themecolor:text1\">&nbsp;<\/span><\/p><p class=\"yiv6440921889msonormal\" style=\"margin:0in;text-align:justify;\ntext-indent:.25in\"><span style=\"font-family:&quot;Times New Roman&quot;,serif;color:black;\nmso-themecolor:text1\">Nella PET (Tomografia ad Emissione di Positroni) ho\nintravisto la possibilit\u00e0 di un miglioramento dell\u2019efficienza di circa 400\nvolte. A giugno del 2000 ho scritto il libro (<\/span><a href=\"https:\/\/drive.google.com\/file\/d\/0BxWfo2ViJ6r5WVFVWnJteENqMWc\/view?usp=sharing\"><span style=\"font-family:&quot;Times New Roman&quot;,serif;background:#EEEEEE\">goo.gl\/ggGGwF<\/span><\/a><span style=\"font-family:&quot;Times New Roman&quot;,serif;color:black;mso-themecolor:text1\">)\nriportando nella prima met\u00e0 lo stato dell\u2019arte delle PET attuali e nell\u2019altra\nmet\u00e0 ho riportato i limiti e le innovazioni tecnologiche per superarli. <o:p><\/o:p><\/span><\/p><p class=\"yiv6440921889msonormal\" style=\"margin:0in;text-align:justify;\ntext-indent:.25in\"><span style=\"font-family:&quot;Times New Roman&quot;,serif;color:black;\nmso-themecolor:text1\">&nbsp;<\/span><\/p><p class=\"yiv6440921889msonormal\" style=\"margin:0in;text-align:justify;\ntext-indent:.25in\"><b><i><span style=\"font-family:&quot;Times New Roman&quot;,serif;\ncolor:black;mso-themecolor:text1\">Ho migliorato l\u2019efficienza delle PET di 400\nvolte allungando il rivelatore, migliorando l\u2019elettronica, semplificando\nl\u2019assemblaggio del rivelatore, usando rivelatori a cristalli spessi ed\neconomici, usando un algoritmo per il riconoscimento pi\u00f9 preciso in grado di\ncatturare un maggior numero di segnali provenienti dai marcatori tumorali al\nminor costo per ogni segnale valido catturato e migliorando la sinergia tra\ntutti i componenti della PET<\/span><\/i><\/b><b><span style=\"font-family:&quot;Times New Roman&quot;,serif;\ncolor:black;mso-themecolor:text1\"> (<\/span><\/b><span style=\"font-family:&quot;Times New Roman&quot;,serif;\ncolor:black;mso-themecolor:text1\">Vedi il video a:<b> <\/b><\/span><b><span style=\"font-family:&quot;Times New Roman&quot;,serif;color:blue\">https:\/\/bit.ly\/<\/span><\/b><a href=\"https:\/\/www.youtube.com\/watch?v=UCMEdp5nEdI\"><b><span style=\"font-family:\n&quot;Times New Roman&quot;,serif\">3vTN8j7<\/span><\/b><\/a><b><span style=\"font-family:\n&quot;Times New Roman&quot;,serif;color:black;mso-themecolor:text1\">)<\/span><\/b><span style=\"font-family:&quot;Times New Roman&quot;,serif;color:black;mso-themecolor:text1\">.&nbsp; <o:p><\/o:p><\/span><\/p><p class=\"yiv6440921889msonormal\" style=\"margin:0in;text-align:justify;\ntext-indent:.25in\"><span style=\"font-family:&quot;Times New Roman&quot;,serif;color:black;\nmso-themecolor:text1\">&nbsp;<\/span><\/p><p class=\"yiv6440921889msonormal\" style=\"margin:0in;text-align:justify;\ntext-indent:.25in\"><span style=\"font-family:&quot;Times New Roman&quot;,serif;color:black;\nmso-themecolor:text1\">La fisica delle particelle e la PET hanno in comune la\nnecessit\u00e0 di estrarre informazioni utili dalla radiazione con la grande\ndifferenza che se il sistema \u00e8 inefficiente, si scopre la particella qualche\nanno dopo, senza troppi danni al di l\u00e0 dei maggiori costi mentre invece esiste\nuna grande differenza nell\u2019applicazione per la diagnostica medica: <b>una PET\nefficiente salva la vita, mentre una non efficiente aumenta principalmente il\nbusiness del cancro<\/b>.<o:p><\/o:p><\/span><\/p><p class=\"yiv6440921889msonormal\" style=\"margin:0in;text-align:justify;\ntext-indent:.25in\"><span style=\"font-family:&quot;Times New Roman&quot;,serif;color:black;\nmso-themecolor:text1\">&nbsp;<\/span><\/p><p class=\"yiv6440921889msonormal\" style=\"margin:0in;text-align:justify;\ntext-indent:.25in\"><span style=\"font-family:&quot;Times New Roman&quot;,serif;color:black;\nmso-themecolor:text1\">La mia invenzione 3D-CBS ha creato un cambiamento\nparadigmatico rivoluzionario nell&#8217;imaging biomedico nel <b>rilevare l&#8217;attivit\u00e0\nfunzionale anomala di tumori delle dimensioni di<\/b> <b>centinaia di cellule\ndel corpo invece di un miliardo di cellule (1 cm<sup>3<\/sup>) o un milione di cellule\n(1 mm<sup>3<\/sup>)<\/b>, ancora prima che si sia verificato qualsiasi\ncambiamento morfologico che potesse essere rilevato da una TAC, RM, ecografia,\necc.<o:p><\/o:p><\/span><\/p><p class=\"yiv6440921889msonormal\" style=\"margin:0in;text-align:justify;\ntext-indent:.25in\"><span style=\"font-family:&quot;Times New Roman&quot;,serif;color:black;\nmso-themecolor:text1\">&nbsp;<\/span><\/p><p class=\"yiv6440921889msonormal\" style=\"margin:0in;text-align:justify;\ntext-indent:.25in\"><span style=\"font-family:&quot;Times New Roman&quot;,serif;color:black;\nmso-themecolor:text1\">Rispetto al mio lavoro precedente negli esperimenti di\nfisica si \u00e8 trattato di risolvere un problema per un rivelatore 25 volte pi\u00f9\npiccolo in cui \u00e8 richiesta l\u2019identificazione di una sola particella (una coppia\ndi fotoni a 511 keV) mentre negli esperimenti di fisica dovevo identificare\nelettroni, adroni, fotoni, muoni, jet, ecc.<o:p><\/o:p><\/span><\/p><p class=\"yiv6440921889msonormal\" style=\"margin:0in;text-align:justify;\ntext-indent:.25in\"><span style=\"font-family:&quot;Times New Roman&quot;,serif;color:black;\nmso-themecolor:text1\">&nbsp;<\/span><\/p><p class=\"yiv6440921889msonormal\" style=\"margin:0in;text-align:justify;\ntext-indent:.25in\"><span style=\"font-family:&quot;Times New Roman&quot;,serif;color:black;\nmso-themecolor:text1\">Invece di ricevere i fondi per realizzare le mie\ninvenzioni a beneficio dell\u2019umanit\u00e0 i colleghi influenti della comunit\u00e0\nscientifica che si spartiscono la torta dei miliardi di dollari dei\ncontribuenti per la ricerca, hanno plagiato e copiato la mia idea\/invenzione,\nmi hanno boicottato, hanno soppresso le mie pubblicazioni e le mie\npresentazioni alle conferenze scientifiche. Alcuni di loro, di tre universit\u00e0\nUSA, si sono appropriati di diversi milioni di dollari (il pi\u00f9 significativo in\nuna sola borsa di ricerca di 15,5 milioni di dollari), ma non essendo in grado\ncostruire la mia idea\/invenzione hanno usato i soldi dei contribuenti americani\nper commissionare la costruzione di una PET lunga chiamata EXPLORER ad <b>una\nditta cinese che ha confermato i miei calcoli nel libro (<\/b><\/span><a href=\"https:\/\/drive.google.com\/file\/d\/0BxWfo2ViJ6r5WVFVWnJteENqMWc\/view?usp=sharing\"><b><span style=\"font-family:&quot;Times New Roman&quot;,serif;background:#EEEEEE\">goo.gl\/ggGGwF<\/span><\/b><\/a><b><span style=\"font-family:&quot;Times New Roman&quot;,serif;color:black;mso-themecolor:text1\">)\nche poteva trovare tumori con 100 cellule cancerose anzich\u00e9 un miliardo.\nTuttavia, un esame sull\u2019EXPLORER costa oltre 10.000 dollari (<\/span><\/b><b><span style=\"font-family:&quot;Times New Roman&quot;,serif;color:blue\">https:\/\/bit.ly\/<\/span><\/b><a href=\"https:\/\/drive.google.com\/file\/d\/161ohRha5sJTvB0DLNkF0gHIDqBiIWtO1\/view?usp=sharing\"><b><span style=\"font-family:&quot;Times New Roman&quot;,serif\">3554QnH<\/span><\/b><\/a><b><span style=\"font-family:&quot;Times New Roman&quot;,serif;color:black;mso-themecolor:text1\">)\ninvece dei 200 dollari sul 3D-CBS (<\/span><\/b><b><span style=\"font-family:&quot;Times New Roman&quot;,serif;\ncolor:blue\">https:\/\/bit.ly\/<\/span><\/b><a href=\"https:\/\/drive.google.com\/file\/d\/1HDCFvFnq5P8apbdcNWkmYjiJ83bEAyed\/view?usp=sharing\"><b><span style=\"font-family:&quot;Times New Roman&quot;,serif\">2V516AN<\/span><\/b><\/a><b><span style=\"font-family:&quot;Times New Roman&quot;,serif;color:black;mso-themecolor:text1\">,\n50 volte in meno).<\/span><\/b><span style=\"font-family:&quot;Times New Roman&quot;,serif;\ncolor:black;mso-themecolor:text1\"> <o:p><\/o:p><\/span><\/p><p class=\"yiv6440921889msonormal\" style=\"margin:0in;text-align:justify;\ntext-indent:.25in\"><span style=\"font-family:&quot;Times New Roman&quot;,serif;color:black;\nmso-themecolor:text1\">&nbsp;<\/span><\/p><p class=\"yiv6440921889msonormal\" style=\"margin:0in;text-align:justify;\ntext-indent:.25in\"><b><span style=\"font-family:&quot;Times New Roman&quot;,serif;\ncolor:black;mso-themecolor:text1\">Questa conferma che la mia invenzione 3D-CBS\ndel 2000 poteva identificare tumori con 100 cellule poteva essere realizzata\ndopo l\u2019incontro che avevo avuto il 6 novembre 2002 con i dirigenti della\nSiemens<\/span><\/b><span style=\"font-family:&quot;Times New Roman&quot;,serif;color:black;\nmso-themecolor:text1\">, il maggiore produttore di PET al mondo, quando avevo\nrisolto il problema di inefficienza delle loro PET corte. Sarebbe stato\nsufficiente che affiancassero 10 PET corte per verificare su una PET lunga i\nmiei calcoli, ma hanno aspettato 18 anni per farlo con la Biograph Vision Quadra,\nsolo quando temevano di perdere una fetta di mercato minacciato dalla PET lunga\nEXPLORER.&nbsp; <o:p><\/o:p><\/span><\/p><p class=\"yiv6440921889msonormal\" style=\"margin:0in;text-align:justify;\ntext-indent:.25in\"><span style=\"font-family:&quot;Times New Roman&quot;,serif;color:black;\nmso-themecolor:text1\">&nbsp;<\/span><\/p><p class=\"yiv6440921889msonormal\" style=\"margin:0in;text-align:justify;\ntext-indent:.25in\"><span style=\"font-family:&quot;Times New Roman&quot;,serif;color:black;\nmso-themecolor:text1\">Il mercato e l\u2019avanzamento tecnologico non \u00e8 dettato dai\nbenefici per l\u2019umanit\u00e0 di salvare vite e risparmiare ma dal profitto di pochi,\ninfatti, l\u2019altro grande produttore di PET al mondo mi ha ripetuto per 20 anni\nche il mercato non era maturo per le PET lunghe \u2026sebbene io continuassi a far\npresente \u201c\u2026<i>la comunit\u00e0 \u00e8 matura per ricevere i benefici di salvare milioni\ndi vite e risparmiare miliardi di dollari<\/i>\u201d. <o:p><\/o:p><\/span><\/p><p class=\"yiv6440921889msonormal\" style=\"margin:0in;text-align:justify;\ntext-indent:.25in\"><span style=\"font-family:&quot;Times New Roman&quot;,serif;color:black;\nmso-themecolor:text1\">&nbsp;<\/span><\/p><p class=\"yiv6440921889msonormal\" style=\"margin:0in;text-align:justify;\ntext-indent:.25in\"><b><span style=\"font-family:&quot;Times New Roman&quot;,serif;\ncolor:red\">Per 20 sono stato boicottato nel dimostrare che la mia invenzione\npu\u00f2 identificare tumori con 100 cellule cancerose, <\/span><\/b><b><span style=\"font-family:&quot;Times New Roman&quot;,serif;color:black;mso-themecolor:text1\">ora\nche questo \u00e8 stato confermato vengo boicottato nella strategia di <\/span><\/b><b><span style=\"font-family:&quot;Times New Roman&quot;,serif;color:red\">effettuare tests di\nscreening ripetitivi a 200 dollari e con l\u2019aiuto del CAD (Computer-Aided\nDiagnosis) <\/span><\/b><b><span style=\"font-family:&quot;Times New Roman&quot;,serif;\ncolor:black;mso-themecolor:text1\">salvare molte vite e risparmiare molto denaro<\/span><\/b><b><span style=\"font-family:&quot;Times New Roman&quot;,serif;color:red\">.<o:p><\/o:p><\/span><\/b><\/p><p class=\"yiv6440921889msonormal\" style=\"margin:0in;text-align:justify;\ntext-indent:.25in\"><span style=\"font-family:&quot;Times New Roman&quot;,serif;color:black;\nmso-themecolor:text1\">&nbsp;<\/span><\/p><p class=\"yiv6440921889msonormal\" align=\"center\" style=\"margin:0in;text-align:center\"><b><span style=\"font-size:12.0pt;font-family:&quot;Times New Roman&quot;,serif;color:black;\nmso-themecolor:text1\">\u201c<i>Non avrei mai pensato che ci fossero cos\u00ec tanti\nostacoli per fare del bene all\u2019umanit\u00e0<\/i>\u201d.<o:p><\/o:p><\/span><\/b><\/p><p class=\"yiv6440921889msonormal\" style=\"margin:0in;text-align:justify\"><b><span style=\"font-family:&quot;Times New Roman&quot;,serif;color:black;mso-themecolor:text1\">&nbsp;<\/span><\/b><\/p><p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:.85pt;margin-bottom:0in;\nmargin-left:1.0pt;text-align:justify;line-height:normal\"><b><span style=\"font-size:12.0pt;font-family:&quot;Arial&quot;,sans-serif;\nletter-spacing:-.25pt;mso-font-width:110%;mso-ansi-language:IT\">&nbsp;<\/span><\/b><\/p><p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:.85pt;margin-bottom:0in;\nmargin-left:1.0pt;text-align:justify;line-height:normal\"><b><span style=\"font-size:12.0pt;font-family:&quot;Arial&quot;,sans-serif;\nletter-spacing:-.25pt;mso-font-width:110%;mso-ansi-language:IT\">Lei<\/span><\/b><b><span style=\"font-size:12.0pt;font-family:\n&quot;Arial&quot;,sans-serif;letter-spacing:-.95pt;mso-font-width:110%;mso-ansi-language:\nIT\"> <\/span><\/b><b><span style=\"font-size:\n12.0pt;font-family:&quot;Arial&quot;,sans-serif;letter-spacing:-.3pt;mso-font-width:110%;\nmso-ansi-language:IT\">ovviamente<\/span><\/b><b><span style=\"font-size:12.0pt;font-family:&quot;Arial&quot;,sans-serif;letter-spacing:-.9pt;\nmso-font-width:110%;mso-ansi-language:IT\"> <\/span><\/b><b><span style=\"font-size:12.0pt;font-family:&quot;Arial&quot;,sans-serif;\nletter-spacing:-.15pt;mso-font-width:110%;mso-ansi-language:IT\">si<\/span><\/b><b><span style=\"font-size:12.0pt;font-family:\n&quot;Arial&quot;,sans-serif;letter-spacing:-.95pt;mso-font-width:110%;mso-ansi-language:\nIT\"> <\/span><\/b><b><span style=\"font-size:\n12.0pt;font-family:&quot;Arial&quot;,sans-serif;letter-spacing:-.25pt;mso-font-width:\n110%;mso-ansi-language:IT\">assume<\/span><\/b><b><span style=\"font-size:12.0pt;font-family:&quot;Arial&quot;,sans-serif;\nletter-spacing:-.9pt;mso-font-width:110%;mso-ansi-language:IT\"> <\/span><\/b><b><span style=\"font-size:12.0pt;font-family:\n&quot;Arial&quot;,sans-serif;letter-spacing:-.15pt;mso-font-width:110%;mso-ansi-language:\nIT\">la<\/span><\/b><b><span style=\"font-size:\n12.0pt;font-family:&quot;Arial&quot;,sans-serif;letter-spacing:-.95pt;mso-font-width:\n110%;mso-ansi-language:IT\"> <\/span><\/b><b><span style=\"font-size:12.0pt;font-family:&quot;Arial&quot;,sans-serif;letter-spacing:-.25pt;\nmso-font-width:110%;mso-ansi-language:IT\">responsabilit\u00e0<\/span><\/b><b><span style=\"font-size:12.0pt;font-family:\n&quot;Arial&quot;,sans-serif;letter-spacing:-1.05pt;mso-font-width:110%;mso-ansi-language:\nIT\"> <\/span><\/b><b><span style=\"font-size:\n12.0pt;font-family:&quot;Arial&quot;,sans-serif;letter-spacing:-.15pt;mso-font-width:\n110%;mso-ansi-language:IT\">di<\/span><\/b><b><span style=\"font-size:12.0pt;font-family:&quot;Arial&quot;,sans-serif;letter-spacing:-1.05pt;\nmso-font-width:110%;mso-ansi-language:IT\"> <\/span><\/b><b><span style=\"font-size:12.0pt;font-family:&quot;Arial&quot;,sans-serif;\nletter-spacing:-.25pt;mso-font-width:110%;mso-ansi-language:IT\">quanto<\/span><\/b><b><span style=\"font-size:12.0pt;font-family:\n&quot;Arial&quot;,sans-serif;letter-spacing:-1.05pt;mso-font-width:110%;mso-ansi-language:\nIT\"> <\/span><\/b><b><span style=\"font-size:\n12.0pt;font-family:&quot;Arial&quot;,sans-serif;letter-spacing:-.25pt;mso-font-width:\n110%;mso-ansi-language:IT\">sostiene<\/span><\/b><b><span style=\"font-size:12.0pt;font-family:&quot;Arial&quot;,sans-serif;\nletter-spacing:-1.05pt;mso-font-width:110%;mso-ansi-language:IT\"> <\/span><\/b><b><span style=\"font-size:12.0pt;font-family:\n&quot;Arial&quot;,sans-serif;mso-font-width:110%;mso-ansi-language:IT\">e<span style=\"letter-spacing:-1.05pt\"> <\/span><span style=\"letter-spacing:-.3pt\">dichiara.<\/span><\/span><\/b><b><span style=\"font-size:12.0pt;font-family:\n&quot;Arial&quot;,sans-serif;mso-ansi-language:IT\"><o:p><\/o:p><\/span><\/b><\/p><p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:.85pt;margin-bottom:0in;\nmargin-left:1.0pt;text-align:justify;line-height:normal\"><b><span style=\"font-size:12.0pt;font-family:&quot;Arial&quot;,sans-serif;\nmso-ansi-language:IT\">&nbsp;<\/span><\/b><\/p><p class=\"MsoBodyText\" style=\"text-indent:17.0pt\"><span style=\"font-size:11.0pt;\nfont-family:&quot;Times New Roman&quot;,serif;letter-spacing:-.15pt;mso-font-width:115%\">Ma<\/span><span style=\"font-size:11.0pt;font-family:&quot;Times New Roman&quot;,serif;letter-spacing:\n-.8pt;mso-font-width:115%\"> <\/span><span style=\"font-size:11.0pt;font-family:\n&quot;Times New Roman&quot;,serif;letter-spacing:-.3pt;mso-font-width:115%\">certo,<\/span><span style=\"font-size:11.0pt;font-family:&quot;Times New Roman&quot;,serif;letter-spacing:\n-.75pt;mso-font-width:115%\"> <\/span><span style=\"font-size:11.0pt;font-family:\n&quot;Times New Roman&quot;,serif;letter-spacing:-.15pt;mso-font-width:115%\">le<\/span><span style=\"font-size:11.0pt;font-family:&quot;Times New Roman&quot;,serif;letter-spacing:\n-.75pt;mso-font-width:115%\"> <\/span><span style=\"font-size:11.0pt;font-family:\n&quot;Times New Roman&quot;,serif;letter-spacing:-.2pt;mso-font-width:115%\">mie<\/span><span style=\"font-size:11.0pt;font-family:&quot;Times New Roman&quot;,serif;letter-spacing:\n-.75pt;mso-font-width:115%\"> <\/span><span style=\"font-size:11.0pt;font-family:\n&quot;Times New Roman&quot;,serif;letter-spacing:-.25pt;mso-font-width:115%\">dichiarazioni<\/span><span style=\"font-size:11.0pt;font-family:&quot;Times New Roman&quot;,serif;letter-spacing:\n-.75pt;mso-font-width:115%\"> <\/span><span style=\"font-size:11.0pt;font-family:\n&quot;Times New Roman&quot;,serif;letter-spacing:-.2pt;mso-font-width:115%\">sono<\/span><span style=\"font-size:11.0pt;font-family:&quot;Times New Roman&quot;,serif;letter-spacing:\n-.75pt;mso-font-width:115%\"> <\/span><span style=\"font-size:11.0pt;font-family:\n&quot;Times New Roman&quot;,serif;letter-spacing:-.3pt;mso-font-width:115%\">basate<\/span><span style=\"font-size:11.0pt;font-family:&quot;Times New Roman&quot;,serif;letter-spacing:\n-.75pt;mso-font-width:115%\"> <\/span><span style=\"font-size:11.0pt;font-family:\n&quot;Times New Roman&quot;,serif;letter-spacing:-.25pt;mso-font-width:115%\">su <\/span><span style=\"font-size:11.0pt;font-family:&quot;Times New Roman&quot;,serif;letter-spacing:\n-.3pt;mso-font-width:115%\">fatti<\/span><span style=\"font-size:11.0pt;\nfont-family:&quot;Times New Roman&quot;,serif;letter-spacing:-.5pt;mso-font-width:115%\"> <\/span><span style=\"font-size:11.0pt;font-family:&quot;Times New Roman&quot;,serif;letter-spacing:\n-.25pt;mso-font-width:115%\">analitici,<\/span><span style=\"font-size:11.0pt;\nfont-family:&quot;Times New Roman&quot;,serif;letter-spacing:-.5pt;mso-font-width:115%\"> <\/span><span style=\"font-size:11.0pt;font-family:&quot;Times New Roman&quot;,serif;letter-spacing:\n-.2pt;mso-font-width:115%\">non<\/span><span style=\"font-size:11.0pt;font-family:\n&quot;Times New Roman&quot;,serif;letter-spacing:-.5pt;mso-font-width:115%\"> <\/span><span style=\"font-size:11.0pt;font-family:&quot;Times New Roman&quot;,serif;letter-spacing:\n-.15pt;mso-font-width:115%\">ho<\/span><span style=\"font-size:11.0pt;font-family:\n&quot;Times New Roman&quot;,serif;letter-spacing:-.5pt;mso-font-width:115%\"> <\/span><span style=\"font-size:11.0pt;font-family:&quot;Times New Roman&quot;,serif;letter-spacing:\n-.25pt;mso-font-width:115%\">niente<\/span><span style=\"font-size:11.0pt;\nfont-family:&quot;Times New Roman&quot;,serif;letter-spacing:-.5pt;mso-font-width:115%\"> <\/span><span style=\"font-size:11.0pt;font-family:&quot;Times New Roman&quot;,serif;letter-spacing:\n-.15pt;mso-font-width:115%\">da<\/span><span style=\"font-size:11.0pt;font-family:\n&quot;Times New Roman&quot;,serif;letter-spacing:-.5pt;mso-font-width:115%\"> <\/span><span style=\"font-size:11.0pt;font-family:&quot;Times New Roman&quot;,serif;letter-spacing:\n-.25pt;mso-font-width:115%\">nascondere,<\/span><span style=\"font-size:11.0pt;\nfont-family:&quot;Times New Roman&quot;,serif;letter-spacing:-.5pt;mso-font-width:115%\"> <\/span><span style=\"font-size:11.0pt;font-family:&quot;Times New Roman&quot;,serif;mso-font-width:\n115%\">\u00e8 <span style=\"letter-spacing:-.3pt\">tutto<\/span><span style=\"letter-spacing:\n-1.05pt\"> <\/span><span style=\"letter-spacing:-.3pt\">pubblicato.<\/span><\/span><span style=\"font-size:11.0pt;font-family:&quot;Times New Roman&quot;,serif\"><o:p><\/o:p><\/span><\/p><p class=\"yiv6440921889msonormal\" style=\"margin:0in;text-align:justify\"><b><span style=\"font-family:&quot;Times New Roman&quot;,serif;color:black;mso-themecolor:text1\">&nbsp;<\/span><\/b><\/p><p class=\"yiv6440921889msonormal\" style=\"margin:0in;text-align:justify\"><b><span style=\"font-family:&quot;Times New Roman&quot;,serif;color:black;mso-themecolor:text1\">&nbsp;<\/span><\/b><\/p><p class=\"yiv6440921889msonormal\" style=\"margin:0in;text-align:justify\"><b><span style=\"font-size:12.0pt;font-family:&quot;Arial&quot;,sans-serif;color:black;mso-themecolor:\ntext1\">La sua estenuante battaglia contro un nemico invisibile ha finalmente\nvisto la luce. Una interrogazione parlamentare al Parlamento Europeo, ce ne\nvuole parlare?<\/span><\/b><span style=\"font-size:12.0pt;font-family:&quot;Arial&quot;,sans-serif;\ncolor:black;mso-themecolor:text1\"><o:p><\/o:p><\/span><\/p><p class=\"yiv6440921889msonormal\" style=\"margin:0in;text-align:justify\"><span style=\"font-family:&quot;Times New Roman&quot;,serif;color:black;mso-themecolor:text1\">&nbsp;<\/span><\/p><p class=\"yiv6440921889msonormal\" style=\"margin:0in;text-align:justify;\ntext-indent:.25in\"><span style=\"font-family:&quot;Times New Roman&quot;,serif;color:black;\nmso-themecolor:text1\">Ho contattato parlamentari e politici di quasi tutte le\nforze politiche prima di riuscire a trovare una persona con il coraggio di\npresentare un\u2019interrogazione al Parlamento Europeo e non ho trovato nessun\nDeputato che la presentasse al Parlamento Italiano.<o:p><\/o:p><\/span><\/p><p class=\"yiv6440921889msonormal\" style=\"margin:0in;text-align:justify;\ntext-indent:.25in\"><span style=\"font-family:&quot;Times New Roman&quot;,serif;color:black;\nmso-themecolor:text1\">&nbsp;<\/span><\/p><p class=\"yiv6440921889msonormal\" style=\"margin:0in;text-align:justify;\ntext-indent:.25in\"><span style=\"font-family:&quot;Times New Roman&quot;,serif;color:black;\nmso-themecolor:text1\">Su questo argomento non ci sono barriere politiche che\ngiustifichino un partito per non aderire per la presenza di un partito\navversario. Non ci sono avversari politici nella lotta contro il cancro, ma\nl\u2019unico avversario comune a tutti noi \u00e8 il cancro e dobbiamo affrontare questa\nlotta uniti. <o:p><\/o:p><\/span><\/p><p class=\"yiv6440921889msonormal\" style=\"margin:0in;text-align:justify;\ntext-indent:.25in\"><span style=\"font-family:&quot;Times New Roman&quot;,serif;color:black;\nmso-themecolor:text1\">&nbsp;<\/span><\/p><p class=\"yiv6440921889msonormal\" style=\"margin:0in;text-align:justify;\ntext-indent:.25in\"><span style=\"font-family:&quot;Times New Roman&quot;,serif;color:black;\nmso-themecolor:text1\">Ho contattato diversi Deputati di diversi colori e sono\nrimasto sconcertato nel modo in cui, tranne uno, si sono dileguati senza\nragione, anzi proprio quando avevano capito che si trattava di una cosa seria,\nche ero stato introdotto alla loro attenzione da un medico, gi\u00e0 membro del\nConsiglio Superiore di Sanit\u00e0 si sono dileguati di fronte a incongruenze enormi\ninconfutabili a danno dei cittadini che necessitano di essere affrontate.<o:p><\/o:p><\/span><\/p><p class=\"yiv6440921889msonormal\" style=\"margin:0in;text-align:justify;\ntext-indent:.25in\"><span style=\"font-family:&quot;Times New Roman&quot;,serif;color:black;\nmso-themecolor:text1\">&nbsp;<\/span><\/p><p style=\"margin: 0in; text-align: justify; text-indent: 0.25in; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\"><span style=\"font-size:11.0pt;color:black;mso-themecolor:text1\">Per questa ragione\nsottolineo il coraggio che ha avuto il Deputato che ha presentato questa\ninterrogazione e l\u2019ho ringraziato a nome dei malati di cancro perch\u00e9 si \u00e8 fatto\n<\/span><span style=\"font-size:11.0pt;color:black;mso-themecolor:text1;\nmso-fareast-language:EN-US\">portavoce degli interessi dei cittadini su una\nquestione cos\u00ec importante che supera ogni barriera e corporativismo di un\npartito rispetto ad un altro, ma che riflette la sensibilit\u00e0 della Sua persona\ncome individuo. <o:p><\/o:p><\/span><\/p><p style=\"margin: 0in; text-align: justify; text-indent: 0.25in; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\"><span style=\"font-size:11.0pt;color:black;mso-themecolor:text1;mso-fareast-language:\nEN-US\">&nbsp;<\/span><\/p><p style=\"margin: 0in; text-align: justify; text-indent: 0.25in; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\"><span style=\"font-size:11.0pt;color:black;mso-themecolor:text1;mso-fareast-language:\nEN-US\">&nbsp;<\/span><\/p><p style=\"margin: 0in; text-align: justify; text-indent: 0.25in; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\"><span style=\"font-size:11.0pt;color:black;mso-themecolor:text1\">Riporto il <b>testo\ndell\u2019interrogazione al Parlamento Europeo<\/b> e invito a leggerla ufficialmente\ntradotta in 24 lingue sul sito dell\u2019Unione Europea. (<\/span><span style=\"color:black;mso-color-alt:windowtext\"><a href=\"https:\/\/www.europarl.europa.eu\/doceo\/document\/E-9-2021-003244_IT.html\"><span style=\"font-size:11.0pt\">https:\/\/www.europarl.europa.eu\/doceo\/document\/E-9-2021-003244_IT.html<\/span><\/a><\/span><span style=\"font-size:11.0pt;color:black;mso-themecolor:text1\">). <o:p><\/o:p><\/span><\/p><p style=\"margin: 0in; text-align: justify; text-indent: 0.25in; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\"><span style=\"font-size:11.0pt;color:black;mso-themecolor:text1\">&nbsp;<\/span><\/p><p style=\"margin: 0in; text-align: justify; text-indent: 0.25in; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\"><b><span style=\"font-size:11.0pt;color:black;mso-themecolor:text1\">\u201c<i>Oggetto: Progetto\n3D-CBS<\/i><\/span><\/b><span style=\"font-size:11.0pt;color:black;mso-themecolor:\ntext1\"> <a name=\"_Hlk76500407\">[<\/a><\/span><span style=\"font-size:11.0pt;color:blue\">https:\/\/bit.ly\/<\/span><a href=\"https:\/\/drive.google.com\/file\/d\/12DRPcQH6gD5oNVavoTUfasPelfYAAkKN\/view?usp=sharing\"><span style=\"font-size:11.0pt\">3xkyf9V<\/span><\/a><span style=\"font-size:11.0pt;\ncolor:black;mso-themecolor:text1\">]<o:p><\/o:p><\/span><\/p><p style=\"margin: 0in; text-align: justify; text-indent: 0.25in; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\"><span style=\"font-size:11.0pt;color:black;mso-themecolor:text1\">&nbsp;<\/span><\/p><p style=\"margin: 0in; text-align: justify; text-indent: 0.25in; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\"><b><i><span style=\"font-size:11.0pt;color:black;mso-themecolor:text1\">La mortalit\u00e0 per\ncancro \u00e8 molto alta e la necessit\u00e0 di avere a disposizione strumenti di\ndiagnosi precoce efficaci applicabili su larga scala \u00e8 sempre pi\u00f9 fondamentale.<o:p><\/o:p><\/span><\/i><\/b><\/p><p style=\"margin: 0in; text-align: justify; text-indent: 0.25in; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\"><b><i><span style=\"font-size:11.0pt;color:black;mso-themecolor:text1\">&nbsp;<\/span><\/i><\/b><\/p><p style=\"margin: 0in; text-align: justify; text-indent: 0.25in; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\"><b><i><span style=\"font-size:11.0pt;color:black;mso-themecolor:text1\">L&#8217;Unione europea ha\nfinanziato la fase I del progetto WPET, un cappotto dal peso di oltre 350Kg da\nindossare per 24 ore per lo screening del cancro, modificato per la fase II con\nuna richiesta di oltre 2 milioni di EUR per un giubbotto dal peso di 10kg, inadeguato\nper la diagnosi precoce.<o:p><\/o:p><\/span><\/i><\/b><\/p><p style=\"margin: 0in; text-align: justify; text-indent: 0.25in; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\"><b><i><span style=\"font-size:11.0pt;color:black;mso-themecolor:text1\">&nbsp;<\/span><\/i><\/b><\/p><p style=\"margin: 0in; text-align: justify; text-indent: 0.25in; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\"><b><i><span style=\"font-size:11.0pt;color:black;mso-themecolor:text1\">Vent&#8217;anni fa \u00e8 stato\nideato un progetto 3D-CBS (Esame Completo del Corpo in 3-D) che presenta i\nseguenti vantaggi: 1) pu\u00f2 identificare cluster di un centinaio di cellule\ncancerose prima che crescano a un miliardo di cellule in 1 cm<span class=\"sup\"><sup>3<\/sup><\/span>&nbsp;e\nsignificherebbe che oltre il 50% delle persone che si sottopongono al test di\nscreening sarebbe salvato; 2) richiede una radiazione molto bassa.<o:p><\/o:p><\/span><\/i><\/b><\/p><p style=\"margin: 0in; text-align: justify; text-indent: 0.25in; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\"><b><i><span style=\"font-size:11.0pt;color:black;mso-themecolor:text1\">&nbsp;<\/span><\/i><\/b><\/p><p style=\"margin: 0in; text-align: justify; text-indent: 0.25in; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\"><b><i><span style=\"font-size:11.0pt;color:black;mso-themecolor:text1\">Alla luce delle\nmisurazioni di terzi che confermano l\u2019efficacia dell&#8217;invenzione 3D-CBS, si chiede\nalla Commissione se intenda condividere con gli operatori e i cittadini uno\nstudio scientifico condiviso considerandone le potenzialit\u00e0<\/span><\/i><\/b><b><span style=\"font-size:11.0pt;color:black;mso-themecolor:text1\">.\u201d<o:p><\/o:p><\/span><\/b><\/p><p style=\"margin: 0in; text-align: justify; text-indent: 0.25in; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\"><span style=\"font-size:11.0pt;color:black;mso-themecolor:text1\">&nbsp;<\/span><\/p><p style=\"margin: 0in; text-align: justify; text-indent: 0.25in; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\"><span style=\"font-size:11.0pt;color:black;mso-themecolor:text1\">&nbsp;<\/span><\/p><p style=\"margin: 0in; text-align: justify; text-indent: 0.25in; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\"><span style=\"font-size:11.0pt;color:black;mso-themecolor:text1\">Ora siamo in attesa\ndi una risposta scritta dalla Commissione al Parlamento Europeo che, guarda\ncaso, proprio il 15 luglio 2021 (<\/span><span style=\"font-size:11.0pt;\ncolor:blue\">https:\/\/bit.ly\/<\/span><span style=\"color:black;mso-color-alt:windowtext\"><a href=\"https:\/\/drive.google.com\/file\/d\/1zdjSF0zszsESdkx2Lk47wn9CwCVt4vZG\/view?usp=sharing\"><span style=\"font-size:11.0pt\">2TigQ2W<\/span><\/a><\/span><span style=\"font-size:11.0pt;\ncolor:black;mso-themecolor:text1\">) la Commissione Europea per Sconfiggere il\nCancro (BECA) ha presentato una bozza di 24 pagine dal titolo \u201c<i>Rafforzare\nl&#8217;Europa nella lotta contro il cancro \u2013 Verso una strategia globale e\ncoordinata<\/i>\u201d (<\/span><span style=\"font-size:11.0pt;color:blue\">https:\/\/bit.ly\/<\/span><span style=\"color:black;mso-color-alt:windowtext\"><a href=\"https:\/\/www.europarl.europa.eu\/doceo\/document\/BECA-PR-693752_EN.pdf\"><span style=\"font-size:11.0pt\">3i3ONOj<\/span><\/a><\/span><span style=\"font-size:11.0pt;\ncolor:black;mso-themecolor:text1\">). <o:p><\/o:p><\/span><\/p><p style=\"margin: 0in; text-align: justify; text-indent: 0.25in; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\"><span style=\"font-size:11.0pt;color:black;mso-themecolor:text1\">&nbsp;<\/span><\/p><p style=\"margin: 0in; text-align: justify; text-indent: 0.25in; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\"><b><span style=\"font-size:11.0pt;color:black;mso-themecolor:text1\">Questo \u00e8 il momento\nbuono per discutere concretamente sull\u2019efficacia delle strategie e mettere a\nconfronto in termini di costi e di vite salvate in 5, 10, 20 e 30 anni le\nstrategie presentate nelle 24 pagine il 15 luglio 2021 (<\/span><\/b><b><span style=\"font-size:11.0pt;color:blue\">https:\/\/bit.ly\/<\/span><\/b><span style=\"color:black;mso-color-alt:windowtext\"><a href=\"https:\/\/www.europarl.europa.eu\/doceo\/document\/BECA-PR-693752_EN.pdf\"><b><span style=\"font-size:11.0pt\">3i3ONOj<\/span><\/b><\/a><\/span><b><span style=\"font-size:11.0pt;color:black;mso-themecolor:text1\">) con la mia\nstrategia descritta in 4 pagine (<\/span><\/b><b><span style=\"font-size:11.0pt;\ncolor:blue\">https:\/\/bit.ly\/<\/span><\/b><span style=\"color:black;mso-color-alt:\nwindowtext\"><a href=\"https:\/\/drive.google.com\/file\/d\/1HDCFvFnq5P8apbdcNWkmYjiJ83bEAyed\/view?usp=sharing\"><b><span style=\"font-size:11.0pt\">2V516AN<\/span><\/b><\/a><\/span><b><span style=\"font-size:11.0pt;color:black;mso-themecolor:text1\">) di salvare in\nEUROPA (<\/span><\/b><span style=\"font-size:11.0pt;color:black;mso-themecolor:\ntext1\">calcolando la proporzione tra le due tabelle)<b>, oltre 20 milioni di\nvite dalla morte prematura da cancro e risparmiare oltre \u20ac2.600 miliardi nei\nprossimi 30 anni costruendo nell\u2019arco di 18 anni 3.700 apparecchiature 3D-CBS.<o:p><\/o:p><\/b><\/span><\/p><p style=\"margin: 0in; text-align: justify; text-indent: 0.25in; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\"><span style=\"font-size:11.0pt;color:black;mso-themecolor:text1\">&nbsp;<\/span><\/p><p class=\"yiv6440921889msonormal\" style=\"margin:0in;text-align:justify;\ntext-indent:.25in\"><span style=\"font-family:&quot;Times New Roman&quot;,serif;color:black;\nmso-themecolor:text1\">Pensate che se si domanda ad un Deputato se preferisce\navere un test di screening del cancro per se stesso, i suoi cari ed i cittadini\nche rappresenta su di un\u2019apparecchiatura in grado di identificare tumori di 100\ncellule cancerose che richiede una dose di radiazione equivalente a quella\nricevuta durante 3-5 viaggi intercontinentali rispetto ad un\u2019apparecchiatura\nche trova solo tumori con un miliardo o diversi milioni di cellule cancerose e\nrichiede un dose di radiazione pericolosa lui risponda \u201c<i>Non lo so<\/i>\u201d?<o:p><\/o:p><\/span><\/p><p class=\"yiv6440921889msonormal\" style=\"margin:0in;text-align:justify;\ntext-indent:.25in\"><span style=\"font-family:&quot;Times New Roman&quot;,serif;color:black;\nmso-themecolor:text1\">&nbsp;<\/span><\/p><p class=\"yiv6440921889msonormal\" style=\"margin:0in;text-align:justify;\ntext-indent:.25in\"><span style=\"font-family:&quot;Times New Roman&quot;,serif;color:black;\nmso-themecolor:text1\">Pensate che <\/span><b><span style=\"font-family:&quot;Times New Roman&quot;,serif;\ncolor:red\">se si domanda al medesimo Deputato se adesso che i miei calcoli\npubblicati sul mio libro del 2000<\/span><\/b><span style=\"font-family:&quot;Times New Roman&quot;,serif;\ncolor:red\"> <\/span><span style=\"font-family:&quot;Times New Roman&quot;,serif;color:black;\nmso-themecolor:text1\">(<\/span><a href=\"https:\/\/drive.google.com\/file\/d\/0BxWfo2ViJ6r5WVFVWnJteENqMWc\/view?usp=sharing\"><span style=\"font-family:&quot;Times New Roman&quot;,serif;background:#EEEEEE\">goo.gl\/ggGGwF<\/span><\/a><span style=\"font-family:&quot;Times New Roman&quot;,serif;color:black;mso-themecolor:text1\">) <\/span><b><span style=\"font-family:&quot;Times New Roman&quot;,serif;color:red\">che sono stati confermati\nsperimentalmente su tre tipi di apparecchiature<\/span><\/b><span style=\"font-family:&quot;Times New Roman&quot;,serif;color:red\"> <\/span><span style=\"font-family:&quot;Times New Roman&quot;,serif;color:black;mso-themecolor:text1\">(EXPLORER,\nBiograph Vision Quadra della Siemens e UPENN-EXLPORER) <\/span><b><span style=\"font-family:&quot;Times New Roman&quot;,serif;color:red\">costruite da terzi che si\nriesce ad identificare tumori con 100 cellule cancerose anche di fronte alle\nevidenze scientifiche sperimentali risponda \u201c<i>Non credo che sia utile per me,\nper i miei cari e per i cittadini che rappresento e quindi non mi interesso<\/i>\u201d?<\/span><\/b><span style=\"font-family:&quot;Times New Roman&quot;,serif;color:black;mso-themecolor:text1\"><o:p><\/o:p><\/span><\/p><p class=\"yiv6440921889msonormal\" style=\"margin:0in;text-align:justify;\ntext-indent:.25in\"><span style=\"font-family:&quot;Times New Roman&quot;,serif;color:black;\nmso-themecolor:text1\">&nbsp;<\/span><\/p><p class=\"yiv6440921889msonormal\" style=\"margin:0in;text-align:justify;\ntext-indent:.25in\"><span style=\"font-family:&quot;Times New Roman&quot;,serif;color:black;\nmso-themecolor:text1\">Pensate che se si domanda al medesimo Deputato se ammette\nche la Commissione Esaminatrice incaricata dal Consiglio Superiore di Sanit\u00e0\nnel 2004 di esaminare il progetto\/invenzione 3D-CBS ha sbagliato nei calcoli e\nnelle valutazioni (riscontrabili nei documenti in archivio <\/span><span style=\"font-family:&quot;Times New Roman&quot;,serif;color:blue\">http:\/\/bit.ly\/<\/span><a href=\"https:\/\/drive.google.com\/file\/d\/0BxWfo2ViJ6r5dGJuQWNzTGpZQ0k\/view?usp=sharing\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">3t0uiWj<\/span><\/a><span style=\"font-family:&quot;Times New Roman&quot;,serif;color:black;mso-themecolor:text1\">)\nbocciando i vantaggi del 3D-CBS con rivelatore lungo (affermando che non\navrebbe fornito vantaggi), che ora sono dimostrate errate da risultati\nsperimentali, tale Deputato ritenga necessario esaminare gli errori, i danni\narrecati ai cittadini e <\/span><b><span style=\"font-family:&quot;Times New Roman&quot;,serif;\ncolor:red\">urgentemente riesaminare la strategia sottoposta in 4 pagine<\/span><\/b><span style=\"font-family:&quot;Times New Roman&quot;,serif;color:black;mso-themecolor:text1\"> (<\/span><b><span style=\"font-family:&quot;Times New Roman&quot;,serif;color:blue\">https:\/\/bit.ly\/<\/span><\/b><a href=\"https:\/\/drive.google.com\/file\/d\/1HDCFvFnq5P8apbdcNWkmYjiJ83bEAyed\/view?usp=sharing\"><b><span style=\"font-family:&quot;Times New Roman&quot;,serif\">2V516AN<\/span><\/b><\/a><span style=\"font-family:&quot;Times New Roman&quot;,serif;color:black;mso-themecolor:text1\">) <\/span><b><span style=\"font-family:&quot;Times New Roman&quot;,serif;color:red\">per salvare in ITALIA 2,6\nmilioni di vite da morte prematura da cancro e risparmiare \u20ac355 miliardi nei\nprossimi 30 anni costruendo 500 apparecchiature 3D-CBS nell\u2019arco di 18 anni?<\/span><\/b><span style=\"font-family:&quot;Times New Roman&quot;,serif;color:black;mso-themecolor:text1\"><o:p><\/o:p><\/span><\/p><p class=\"yiv6440921889msonormal\" style=\"margin:0in;text-align:justify;\ntext-indent:.25in\"><span style=\"font-family:&quot;Times New Roman&quot;,serif;color:black;\nmso-themecolor:text1\">&nbsp;<\/span><\/p><p class=\"yiv6440921889msonormal\" style=\"margin:0in;text-align:justify;\ntext-indent:.25in\"><span style=\"font-family:&quot;Times New Roman&quot;,serif;color:black;\nmso-themecolor:text1\">&nbsp;A questo punto non\nsolo un Deputato ma <b>tutti i Deputati dovrebbero essere d\u2019accordo nel\npresentare un\u2019Interrogazione al Parlamento Italiano che richiede alle persone\nresponsabili delle varie commissioni che gestiscono e\/o definiscono le\nstrategie che costano agli italiani \u20ac20 miliardi annuali per il cancro e ai\nMinistri della Ricerca Scientifica e della Salute di analizzare la mia\nstrategia a<\/b> (<\/span><b><span style=\"font-family:&quot;Times New Roman&quot;,serif;\ncolor:blue\">https:\/\/bit.ly\/<\/span><\/b><a href=\"https:\/\/drive.google.com\/file\/d\/1HDCFvFnq5P8apbdcNWkmYjiJ83bEAyed\/view?usp=sharing\"><b><span style=\"font-family:&quot;Times New Roman&quot;,serif\">2V516AN<\/span><\/b><\/a><span style=\"font-family:&quot;Times New Roman&quot;,serif;color:black;mso-themecolor:text1\">)\ne correggere gli errori del CSS in merito alla revisione del progetto 3D-CBS\ndel 2004.<o:p><\/o:p><\/span><\/p><p class=\"yiv6440921889msonormal\" style=\"margin:0in;text-align:justify;\ntext-indent:.25in\"><span style=\"font-family:&quot;Times New Roman&quot;,serif;color:black;\nmso-themecolor:text1\">&nbsp;<\/span><\/p><p class=\"yiv6440921889msonormal\" style=\"margin:0in;text-align:justify;\ntext-indent:.25in\"><b><span style=\"font-family:&quot;Times New Roman&quot;,serif;\ncolor:black;mso-themecolor:text1\">Il Ministro dell\u2019Universit\u00e0 e della Ricerca\nScientifica, Dott. Gaetano Manfredi e il Vice-Ministro della Salute, Dott. Pier\nPaolo Sileri erano presenti, partecipando il 12 dicembre 2020 alla Conferenza\ndei Ricercatori Italiani nel Mondo<\/span><\/b><span style=\"font-family:&quot;Times New Roman&quot;,serif;\ncolor:black;mso-themecolor:text1\"> svoltasi in video conferenza da Houston in\nTexas, <b>insieme alla RAI che curava la presentazione<\/b> della Conferenza\nhanno assistito al comportamento oltraggioso e incivile documentato su Facebook\n(<\/span><span style=\"font-family:&quot;Times New Roman&quot;,serif;color:blue\">http:\/\/bit.ly\/<\/span><a href=\"https:\/\/drive.google.com\/file\/d\/1zcl1b2OH0n1vJXfpO_HY1nRIClOa8_Vc\/view?usp=sharing\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">2LbRorX<\/span><\/a><span style=\"font-family:&quot;Times New Roman&quot;,serif;color:black;mso-themecolor:text1\">)\nin cui gli organizzatori hanno soppresso la trasparenza nella scienza, addirittura\nfacendo apparire il contrario delle loro azioni di censura ed esclusione senza\nassumersi la responsabilit\u00e0 di fornire una ragione.<o:p><\/o:p><\/span><\/p><p class=\"yiv6440921889msonormal\" style=\"margin:0in;text-align:justify;\ntext-indent:.25in\"><span style=\"font-family:&quot;Times New Roman&quot;,serif;color:black;\nmso-themecolor:text1\">&nbsp;<\/span><\/p><p style=\"margin: 0in; text-align: justify; text-indent: 0.25in; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\"><span style=\"font-size:11.0pt;color:black;mso-themecolor:text1\">Nell\u2019eventualit\u00e0 che\nun Deputato o dirigente con cariche di responsabilit\u00e0 nel settore ritenga che\nnon sia utile e di beneficio avere un\u2019apparecchiatura in grado di identificare\n100 cellule cancerose anzich\u00e9 un miliardo o diversi milioni, vi invito a dire a\nquesta persona di contattarmi perch\u00e9 avrei informazioni utili da condividere.<o:p><\/o:p><\/span><\/p><p style=\"margin: 0in; text-align: justify; text-indent: 0.25in; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\"><span style=\"font-size:11.0pt;color:black;mso-themecolor:text1\">&nbsp;<\/span><\/p><p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:.85pt;margin-bottom:0in;\nmargin-left:1.0pt;line-height:normal\"><b><span style=\"font-size:12.0pt;font-family:&quot;Arial&quot;,sans-serif;mso-font-width:110%;\nmso-ansi-language:IT\">Mi<span style=\"letter-spacing:-1.7pt\"> <\/span><span style=\"letter-spacing:-.15pt\">scuso<\/span><span style=\"letter-spacing:-1.7pt\"> <\/span>se<span style=\"letter-spacing:-1.7pt\"> <\/span><span style=\"letter-spacing:-.15pt\">sono<\/span><span style=\"letter-spacing:-1.65pt\"> <\/span><span style=\"letter-spacing:-.2pt\">ripetitivo<\/span><span style=\"letter-spacing:-1.7pt\"> <\/span>ma<span style=\"letter-spacing:-1.7pt\"> <\/span>le<span style=\"letter-spacing:-1.7pt\"> <\/span>sue<span style=\"letter-spacing:-1.65pt\"> <\/span><span style=\"letter-spacing:-.15pt\">sono affermazioni <\/span><span style=\"letter-spacing:\n-.25pt\">piuttosto <\/span><span style=\"letter-spacing:-.15pt\">forti, devo <\/span><span style=\"letter-spacing:-.2pt\">farle presente <\/span>che lei <span style=\"letter-spacing:-.2pt\">ovviamente <\/span>si <span style=\"letter-spacing:\n-.15pt\">assume <\/span>la <span style=\"letter-spacing:-.2pt\">responsabilit\u00e0 <\/span>di\n<span style=\"letter-spacing:-.2pt\">quanto sostiene <\/span>e <span style=\"letter-spacing:-.2pt\">dichiara<\/span><span style=\"letter-spacing:-.75pt\">\n<\/span>e<span style=\"letter-spacing:-.75pt\"> <\/span>che<span style=\"letter-spacing:\n-.75pt\"> <\/span><span style=\"letter-spacing:-.25pt\">sto<\/span><span style=\"letter-spacing:-.75pt\"> <\/span><span style=\"letter-spacing:-.25pt\">raccogliendo<\/span><span style=\"letter-spacing:-.75pt\"> <\/span>in<span style=\"letter-spacing:-.75pt\"> <\/span><span style=\"letter-spacing:-.2pt\">questa intervista.<\/span><\/span><\/b><b><span style=\"font-size:12.0pt;font-family:\n&quot;Arial&quot;,sans-serif;mso-ansi-language:IT\"><o:p><\/o:p><\/span><\/b><\/p><p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:.85pt;margin-bottom:0in;\nmargin-left:1.0pt;text-align:justify;line-height:normal\"><b><span style=\"font-family:&quot;Times New Roman&quot;,serif;mso-ansi-language:\nIT\">&nbsp;<\/span><\/b><\/p><p class=\"yiv6440921889msonormal\" style=\"margin:0in;text-align:justify;\ntext-indent:.25in\"><span style=\"font-family:&quot;Times New Roman&quot;,serif;mso-font-width:\n115%\">Ma <span style=\"letter-spacing:-.2pt\">certo, <\/span>\u00e8 <span style=\"letter-spacing:-.2pt\">tutto documentato <\/span>e <span style=\"letter-spacing:\n-.2pt\">documentabile. <\/span><\/span><span style=\"font-family:&quot;Times New Roman&quot;,serif;\ncolor:black;mso-themecolor:text1\">Una persona a me molto cara il 28 gennaio\n2021 ha sentito una massa toccandosi l&#8217;addome. La TAC ha rilevato tre masse, la\npi\u00f9 grande di 7,4 cm x 6,4 cm x 9,0 cm alle ovaie che si sono rivelate tumori. <o:p><\/o:p><\/span><\/p><p class=\"yiv6440921889msonormal\" style=\"margin:0in;text-align:justify;\ntext-indent:.25in\"><span style=\"font-family:&quot;Times New Roman&quot;,serif;color:black;\nmso-themecolor:text1\">&nbsp;<\/span><\/p><p class=\"MsoNormal\" style=\"margin-bottom:0in;text-align:justify;text-indent:\n.25in;line-height:normal\"><span style=\"font-family:&quot;Times New Roman&quot;,serif;\ncolor:black;mso-themecolor:text1;mso-ansi-language:IT\">Quello che \u00e8 successo a\nlei pu\u00f2 succedere a chiunque di noi. Non ha mai fumato, non beve, \u00e8 magra, va\nin palestra, segue una dieta sana, cammina tutti i giorni, ha fatto\nregolarmente tutti i possibili test di screening disponibili (mammografia,\ncolonscopia, ecc.) e i pi\u00f9 importanti test di screening ogni anno tra i 27\nprevisti da <\/span><span lang=\"EN-US\"><a href=\"https:\/\/r20.rs6.net\/tn.jsp?f=001rOTjcKlLguBBv-zXKSLuUtsBerHj72jhQq9QXczFxAgzp3ORQKvtb7UM44lbQCBn2WdccgrSskuUuKXBZuNiY2xiuVQ9IetNY7sXyQeKtn9dnkrjVvytXruGJqApBxQiJMzSApVLGYLP6xPOFWVQKaDGQOphiLjW&amp;c=&amp;ch=\" target=\"_blank\"><span lang=\"IT\" style=\"font-family:&quot;Times New Roman&quot;,serif;\nmso-fareast-font-family:&quot;Times New Roman&quot;;mso-ansi-language:IT\">www.lifelinescreening.com<\/span><\/a><\/span><span style=\"font-family:&quot;Times New Roman&quot;,serif;color:blue;mso-ansi-language:IT\">.<\/span><span style=\"font-family:&quot;Times New Roman&quot;,serif;color:black;mso-themecolor:text1;\nmso-ansi-language:IT\"> <o:p><\/o:p><\/span><\/p><p class=\"MsoNormal\" style=\"margin-bottom:0in;text-align:justify;text-indent:\n.25in;line-height:normal\"><span style=\"font-family:&quot;Times New Roman&quot;,serif;\ncolor:black;mso-themecolor:text1;mso-ansi-language:IT\">&nbsp;<\/span><\/p><p class=\"MsoNormal\" style=\"margin-bottom:0in;text-align:justify;text-indent:\n.25in;line-height:normal\"><span style=\"font-family:&quot;Times New Roman&quot;,serif;\ncolor:black;mso-themecolor:text1;mso-ansi-language:IT\">&nbsp;<\/span><\/p><p class=\"MsoNormal\" style=\"margin-bottom:0in;text-align:justify;text-indent:\n.25in;line-height:normal\"><b><span style=\"font-family:&quot;Times New Roman&quot;,serif;\ncolor:black;mso-themecolor:text1;mso-ansi-language:IT\">Tutti questi test di\nscreening l&#8217;hanno rassicurata sul fatto che non aveva il cancro, tuttavia,\nnessun test di screening \u00e8 stato in grado di rilevare un tumore primario di\noltre due miliardi di cellule cancerose nell&#8217;arco di quattro-dieci anni prima\nche rompesse la sua struttura e si trasformasse in metastasi intaccando altri\norgani.<\/span><\/b><span style=\"font-family:&quot;Times New Roman&quot;,serif;color:black;\nmso-themecolor:text1;mso-ansi-language:IT\"> <o:p><\/o:p><\/span><\/p><p class=\"MsoNormal\" style=\"margin-bottom:0in;text-align:justify;text-indent:\n.25in;line-height:normal\"><span style=\"font-family:&quot;Times New Roman&quot;,serif;\ncolor:black;mso-themecolor:text1;mso-ansi-language:IT\">&nbsp;<\/span><\/p><p class=\"MsoNormal\" style=\"margin-bottom:0in;text-align:justify;text-indent:\n.25in;line-height:normal\"><span style=\"font-family:&quot;Times New Roman&quot;,serif;\ncolor:black;mso-themecolor:text1;mso-ansi-language:IT\">Quando il chirurgo,\nspecializzato in tumori alle ovaie, ha aperto il suo addome, l&#8217;8 marzo 2021, si\n\u00e8 reso conto che quelli erano tumori secondari e quello primario, da 2,5 cm con\npi\u00f9 di due miliardi di cellule cancerose all&#8217;appendice, era l\u00ec presente da pi\u00f9\ndi quattro anni (si stima da 4 a 10 anni) e non \u00e8 stato rilevato dalla TAC,\ndagli Ultrasuoni e da tutti i dispositivi o le procedure diagnostiche esistenti\na cui si \u00e8 sottoposta negli ultimi anni, inclusa l&#8217;ultima l&#8217;8 febbraio 2021.<o:p><\/o:p><\/span><\/p><p class=\"MsoNormal\" style=\"margin-bottom:0in;text-align:justify;text-indent:\n.25in;line-height:normal\"><span style=\"font-family:&quot;Times New Roman&quot;,serif;\ncolor:black;mso-themecolor:text1;mso-ansi-language:IT\">&nbsp;<\/span><\/p><p class=\"MsoNormal\" style=\"margin-bottom:0in;text-align:justify;text-indent:\n.25in;line-height:normal\"><span style=\"font-family:&quot;Times New Roman&quot;,serif;\ncolor:black;mso-themecolor:text1;mso-ansi-language:IT\">Il mio dispositivo\n3D-CBS avrebbe potuto rilevarlo anni fa, quando aveva meno di 100 cellule\ncancerose. Se la mia invenzione 3D-CBS fosse stata finanziata 21 anni fa, il\nsuo tumore avrebbe potuto essere rimosso con una semplice procedura chirurgica,\nprima che si rompesse la sua struttura e si metastatizzasse nel peritoneo,\ninteressando molti altri organi. <o:p><\/o:p><\/span><\/p><p class=\"MsoNormal\" style=\"margin-bottom:0in;text-align:justify;text-indent:\n.25in;line-height:normal\"><span style=\"font-family:&quot;Times New Roman&quot;,serif;\ncolor:black;mso-themecolor:text1;mso-ansi-language:IT\">&nbsp;<\/span><\/p><p class=\"MsoNormal\" style=\"margin-bottom:0in;text-align:justify;text-indent:\n.25in;line-height:normal\"><span style=\"font-family:&quot;Times New Roman&quot;,serif;\ncolor:black;mso-themecolor:text1;mso-ansi-language:IT\">Invece l&#8217;8 marzo 2021,\nil chirurgo ha affrontato una situazione disastrosa quando le ha aperto\nl&#8217;addome perch\u00e9 nessuno dei dispositivi di imaging medico \u00e8 stato in grado di\nrilevarlo prima ed ha dovuto rimuovere, insieme ai tumori, le ovaie, l\u2019utero,\nle Tube di Falloppio e l\u2019appendice. Il secondo chirurgo il 25 maggio 2021, ha\nasportato la milza, che era totalmente compromessa, due piccoli tumori al\nfegato, tumori ai tessuti adiposi nel peritoneo, ha raschiato il colon e il\npancreas attaccati dalle cellule cancerose ed ha avviato la procedura HIPEC che\nfa circolare per 90 minuti nell&#8217;addome 14 litri di fluido chemioterapico a 41\u00b0\nC per uccidere le cellule tumorali a 40\u00b0 C in metastasi nel peritoneo.<o:p><\/o:p><\/span><\/p><p class=\"MsoNormal\" style=\"margin-bottom:0in;text-align:justify;text-indent:\n.25in;line-height:normal\"><span style=\"font-family:&quot;Times New Roman&quot;,serif;\ncolor:black;mso-themecolor:text1;mso-ansi-language:IT\">&nbsp;<\/span><\/p><p class=\"MsoNormal\" style=\"margin-bottom:0in;text-align:justify;text-indent:\n22.5pt;line-height:normal\"><span style=\"font-family:&quot;Times New Roman&quot;,serif;\ncolor:black;mso-themecolor:text1;mso-ansi-language:IT\">Dal 25 maggio 2021 al 28\nluglio sono andato ogni giorno in ospedale e posso testimoniare il dolore, la\nsofferenza, vomito, nausea, ecc. che ha subito questa persona cara e le\ndifficolt\u00e0 dei medici, chirurghi, oncologi infermieri a causa della mancata\ndiagnosi precoce. In coma, e coma indotto per 6 giorni, con un tubo\nnasogastrico e altri cateteri che sono ancora presenti dopo pi\u00f9 di due mesi. Ha\ntrascorso 13 giorni in terapia intensiva, \u00e8 stata affetta da polmonite, le \u00e8\nstato prelevato mezzo litro di liquido dal polmone destro. \u00c8 stata intubata con\nil ventilatore per 5 giorni, che \u00e8 stato rimosso per 3 giorni e rimesso per\naltri 3 giorni.<o:p><\/o:p><\/span><\/p><p class=\"MsoNormal\" style=\"margin-bottom:0in;text-align:justify;text-indent:\n22.5pt;line-height:normal\"><span style=\"font-family:&quot;Times New Roman&quot;,serif;\ncolor:black;mso-themecolor:text1;mso-ansi-language:IT\">&nbsp;<\/span><\/p><p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:28.3pt;margin-bottom:\n0in;margin-left:27.0pt;text-align:justify;line-height:normal\"><b><i><span style=\"font-size:12.0pt;font-family:&quot;Times New Roman&quot;,serif;color:red;\nmso-ansi-language:IT\">\u201cCi\u00f2 che \u00e8 necessario in futuro per la persona a me molto\ncara e per milioni di persone a cui \u00e8 stato diagnosticato un cancro \u00e8 un test\ndi screening sicuro con la mia invenzione 3D-CBS di 21 anni fa a $ 200\/test\nogni due mesi (tre o sei mesi come raccomandato dal medico), abbastanza\nsensibile da rilevare meno di 100 cellule cancerose prima di una ripresa della\ncrescita del cancro a un milione (1 mm<sup>3<\/sup>) o un miliardo (1 cm<sup>3<\/sup>)\ndi cellule cancerose. Chi non fosse d\u2019accordo su ci\u00f2 ha il dovere di esprimere\nil suo disaccordo perch\u00e9 si tratta di una cosa seria\u201d.<o:p><\/o:p><\/span><\/i><\/b><\/p><p class=\"MsoNormal\" style=\"margin-bottom:0in;text-align:justify;text-indent:\n22.5pt;line-height:normal\"><span style=\"font-family:&quot;Times New Roman&quot;,serif;\ncolor:black;mso-themecolor:text1;mso-ansi-language:IT\">&nbsp;<\/span><\/p><p class=\"MsoNormal\" style=\"margin-bottom:0in;text-align:justify;text-indent:\n22.5pt;line-height:normal\"><span style=\"font-family:&quot;Times New Roman&quot;,serif;\ncolor:black;mso-themecolor:text1;mso-ansi-language:IT\">&nbsp;<\/span><\/p><p style=\"margin: 0in; text-align: justify; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\"><b><span style=\"font-family:&quot;Arial&quot;,sans-serif;color:black;mso-themecolor:text1\">Intuiamo\nda quanto ci racconta che anche in una battaglia di civilt\u00e0 come la sua esiste\nun mondo fatto di interessi economici che si fondano su macchinazioni imposte\nad arte, soluzioni chiuse nel cassetto o addirittura infangate per mantenere\nvivo il business della malattia, ma \u00e8 pensabile che al giorno d&#8217;oggi gli\nstrumenti o le possibili soluzioni nella lotta contro il cancro debbano\nsottostare al gioco delle multinazionali, mentre la gente muore?<\/span><\/b><i><span style=\"font-family:&quot;Arial&quot;,sans-serif;color:black;mso-themecolor:text1\"><o:p><\/o:p><\/span><\/i><\/p><p class=\"yiv6440921889msonormal\" style=\"margin:0in;text-align:justify;\ntext-indent:.25in\"><span style=\"font-family:&quot;Times New Roman&quot;,serif;color:black;\nmso-themecolor:text1\">&nbsp;<\/span><\/p><p class=\"MsoNormal\" style=\"margin-bottom:0in;text-align:justify;text-indent:\n22.5pt;line-height:normal\"><span style=\"font-family:&quot;Times New Roman&quot;,serif;\ncolor:black;mso-themecolor:text1;mso-ansi-language:IT\">Purtroppo quanto lei\ndice \u00e8 la triste realt\u00e0 che \u201c<i>gli strumenti e le possibili soluzioni nella\nlotta contro il cancro debbano sottostare al gioco delle multinazionali, mentre\nla gente muore<\/i>\u201d. Voi in Italia non toccate con mano questa realt\u00e0 e vi\nrendete conto solo se leggete e vi informate, mentre nel piccolo della vita\nquotidiana noi qui negli Stati Uniti, come in qualsiasi paese con un sistema\ndell\u2019assistenza sanitaria privata in cui il vero interesse di chi la fornisce\nnon \u00e8 di rendere un servizio al cittadino, ma di avere un maggior profitto, \u00e8\ninevitabile che ci scontriamo molte volte con questa realt\u00e0. In che modo si ha\nun maggior profitto? Purtroppo, la risposta logica \u00e8: \u201c<i>negando un servizio<\/i>\u201d.<o:p><\/o:p><\/span><\/p><p class=\"MsoNormal\" style=\"margin-bottom:0in;text-align:justify;text-indent:\n22.5pt;line-height:normal\"><span style=\"font-family:&quot;Times New Roman&quot;,serif;\ncolor:black;mso-themecolor:text1;mso-ansi-language:IT\">&nbsp;<\/span><\/p><p class=\"MsoNormal\" style=\"margin-bottom:0in;text-align:justify;text-indent:\n22.5pt;line-height:normal\"><span style=\"font-family:&quot;Times New Roman&quot;,serif;\ncolor:black;mso-themecolor:text1;mso-ansi-language:IT\">Quindi non mi sorprende\nla sua affermazione, ma in che modo la si pu\u00f2 contrastare e far si che sia\nrispettata la dignit\u00e0 umana ed il diritto alla salute?<o:p><\/o:p><\/span><\/p><p class=\"MsoNormal\" style=\"margin-bottom:0in;text-align:justify;text-indent:\n22.5pt;line-height:normal\"><span style=\"font-family:&quot;Times New Roman&quot;,serif;\ncolor:black;mso-themecolor:text1;mso-ansi-language:IT\">&nbsp;<\/span><\/p><p class=\"MsoNormal\" style=\"margin-bottom:0in;text-align:justify;text-indent:\n22.5pt;line-height:normal\"><b><span style=\"font-family:&quot;Times New Roman&quot;,serif;\ncolor:black;mso-themecolor:text1;mso-ansi-language:IT\">E\u2019 necessario esporre le\nincongruenze a danno dei pi\u00f9 deboli e poi in un paese civile, culturalmente avanzato\nnel rispettare le leggi della natura (La Scienza), le leggi dello Stato e della\nCostituzione (\u201cRule of Law\u201d), l\u2019etica professionale o codice della condotta\netica e la regola d\u2019oro, si deve far riferimento a queste leggi e regole per\nfar desistere o punire chi le viola.<o:p><\/o:p><\/span><\/b><\/p><p class=\"MsoNormal\" style=\"margin-bottom:0in;text-align:justify;text-indent:\n22.5pt;line-height:normal\"><span style=\"font-family:&quot;Times New Roman&quot;,serif;\ncolor:black;mso-themecolor:text1;mso-ansi-language:IT\">&nbsp;<\/span><\/p><p class=\"MsoNormal\" style=\"margin-bottom:0in;text-align:justify;text-indent:\n22.5pt;line-height:normal\"><span style=\"font-family:&quot;Times New Roman&quot;,serif;\ncolor:black;mso-themecolor:text1;mso-ansi-language:IT\">Non \u00e8 mia intenzione\ninsultare, denigrare o diffamare nessuno, ma da uomo di scienza presento invece\ndati inconfutabili e propongo dei test sperimentali che permettono di\nverificare con misure su di una popolazione campione la fondatezza dei miei\ncalcoli e rivendicazioni per far emergere la verit\u00e0 e le incongruenze in difesa\ndella Scienza e dei pi\u00f9 deboli ingannati o danneggiati da chi queste\nregole\/leggi. <o:p><\/o:p><\/span><\/p><p class=\"MsoNormal\" style=\"margin-bottom:0in;text-align:justify;text-indent:\n22.5pt;line-height:normal\"><span style=\"font-family:&quot;Times New Roman&quot;,serif;\ncolor:black;mso-themecolor:text1;mso-ansi-language:IT\">&nbsp;<\/span><\/p><p class=\"MsoNormal\" style=\"margin-bottom:0in;text-align:justify;text-indent:\n22.5pt;line-height:normal\"><span style=\"font-family:&quot;Times New Roman&quot;,serif;\ncolor:black;mso-themecolor:text1;mso-ansi-language:IT\">Poi serve il vostro\naiuto di giornalisti e dei media che informano i cittadini ed il pi\u00f9 delle\nvolte chi viola le regole elencate sopra si corregge e\/o si assume le proprie\nresponsabilit\u00e0 e se non lo fa, si deve ricorrere a degli avvocati ed ai\nTribunali.<o:p><\/o:p><\/span><\/p><p class=\"MsoNormal\" style=\"margin-bottom:0in;text-align:justify;text-indent:\n22.5pt;line-height:normal\"><span style=\"font-family:&quot;Times New Roman&quot;,serif;\ncolor:black;mso-themecolor:text1;mso-ansi-language:IT\">&nbsp;<\/span><\/p><p class=\"MsoNormal\" style=\"margin-bottom:0in;text-align:justify;text-indent:\n22.5pt;line-height:normal\"><span style=\"font-family:&quot;Times New Roman&quot;,serif;\ncolor:black;mso-themecolor:text1;mso-ansi-language:IT\">Una grande difficolt\u00e0\nche ho trovato \u00e8 quella di far capire al cittadino l\u2019incongruenza ed il passo\nlogico per risolverla.<o:p><\/o:p><\/span><\/p><p class=\"MsoNormal\" style=\"margin-bottom:0in;text-align:justify;text-indent:\n22.5pt;line-height:normal\"><span style=\"font-family:&quot;Times New Roman&quot;,serif;\ncolor:black;mso-themecolor:text1;mso-ansi-language:IT\">&nbsp;<\/span><\/p><p class=\"MsoNormal\" style=\"margin-bottom:0in;text-align:justify;text-indent:\n22.5pt;line-height:normal\"><span style=\"font-family:&quot;Times New Roman&quot;,serif;\ncolor:black;mso-themecolor:text1;mso-ansi-language:IT\">Galileo aveva avuto\nun\u2019idea brillante che aveva dato molto fastidio ai luminari ed alla Chiesa.\nAveva spiegato le argomentazioni a favore e contrarie al sistema geocentrico\n(terra al centro dell\u2019Universo) ed eliocentrico (Il sole al centro del sistema\nsolare) impostando un dialogo tra Salviati (eliocentrico) e Simplicio\n(geocentrico) con il terzo interlocutore Sagredo che rappresenta il discreto\nlettore che interviene nelle discussioni chiedendo delucidazioni, contribuendo\ncon argomenti pi\u00f9 colloquiali.<o:p><\/o:p><\/span><\/p><p class=\"MsoNormal\" style=\"margin-bottom:0in;text-align:justify;text-indent:\n22.5pt;line-height:normal\"><span style=\"font-family:&quot;Times New Roman&quot;,serif;\ncolor:black;mso-themecolor:text1;mso-ansi-language:IT\">&nbsp;<\/span><\/p><p class=\"MsoNormal\" style=\"margin-bottom:0in;text-align:justify;text-indent:\n22.5pt;line-height:normal\"><span style=\"font-family:&quot;Times New Roman&quot;,serif;\ncolor:black;mso-themecolor:text1;mso-ansi-language:IT\">Io ho iniziato un\ndialogo simile su Facebook (<\/span><span style=\"font-family:&quot;Times New Roman&quot;,serif;\nmso-ansi-language:IT\">https:\/\/bit.ly\/<\/span><span lang=\"EN-US\"><a href=\"https:\/\/www.facebook.com\/permalink.php?story_fbid=4282181295151107&amp;id=114803041888974\"><span lang=\"IT\" style=\"font-family:&quot;Times New Roman&quot;,serif;mso-ansi-language:IT\">3kcugIQ<\/span><\/a><\/span><span style=\"font-family:&quot;Times New Roman&quot;,serif;color:black;mso-themecolor:text1;\nmso-ansi-language:IT\">) creando due personaggi: il CURIOSO e il RAGIONEVOLE ed\nintendo continuare questo dialogo.<o:p><\/o:p><\/span><\/p><p class=\"MsoNormal\" style=\"margin-bottom:0in;text-align:justify;text-indent:\n22.5pt;line-height:normal\"><span style=\"font-family:&quot;Times New Roman&quot;,serif;\ncolor:black;mso-themecolor:text1;mso-ansi-language:IT\">&nbsp;<\/span><\/p><p class=\"MsoNormal\" style=\"margin-bottom:0in;text-align:justify;text-indent:\n22.5pt;line-height:normal\"><span style=\"font-family:&quot;Times New Roman&quot;,serif;\ncolor:black;mso-themecolor:text1;mso-ansi-language:IT\">Ad esempio in questo\ndialogo emerge che l\u2019ITALIA spende \u20ac20 miliardi all\u2019anno per il cancro (<\/span><span style=\"font-family:&quot;Times New Roman&quot;,serif;color:blue;mso-ansi-language:IT\">https:\/\/bit.ly\/<\/span><span lang=\"EN-US\"><a href=\"https:\/\/www.aiom.it\/tumori-ogni-anno-in-italia-costano-20-miliardi-di-euro-servono-piu-risorse-per-affrontare-la-fase-3-della-pandemia\/\"><span lang=\"IT\" style=\"font-family:&quot;Times New Roman&quot;,serif;mso-ansi-language:IT\">3qVv9pS<\/span><\/a><\/span><span style=\"font-family:&quot;Times New Roman&quot;,serif;color:black;mso-themecolor:text1;\nmso-ansi-language:IT\">), mentre l<b>\u2019unica volta che si&nbsp; verificata una diminuzione dei morti da\ncancro in Italia&nbsp; si \u00e8&nbsp; trattato di 1.134 vite salvate tra il\n2012&nbsp; e il 2013<\/b>&nbsp; (<\/span><span style=\"font-family:&quot;Times New Roman&quot;,serif;\ncolor:blue;mso-ansi-language:IT\">https:\/\/bit.ly\/<\/span><span lang=\"EN-US\"><a href=\"https:\/\/drive.google.com\/file\/d\/1qsK_hBB1s9AnGZQAkINor1rRowziccRT\/view?usp=sharing\"><span lang=\"IT\" style=\"font-family:&quot;Times New Roman&quot;,serif;mso-ansi-language:IT\">3fUUDjW<\/span><\/a><\/span><span style=\"font-family:&quot;Times New Roman&quot;,serif;color:black;mso-themecolor:text1;\nmso-ansi-language:IT\">), mentre negli altri anni i decessi da cancro sono\naumentati in assenza di un incremento della popolazione (<\/span><span style=\"font-family:&quot;Times New Roman&quot;,serif;color:blue;mso-ansi-language:IT\">https:\/\/bit.ly\/<\/span><span lang=\"EN-US\"><a href=\"https:\/\/drive.google.com\/file\/d\/1PXZLQXpGgnWPsPubVkwDF1od7Q3Ue8Qo\/view?usp=sharing\"><span lang=\"IT\" style=\"font-family:&quot;Times New Roman&quot;,serif;mso-ansi-language:IT\">3pv3qwe<\/span><\/a><\/span><span style=\"font-family:&quot;Times New Roman&quot;,serif;color:black;mso-themecolor:text1;\nmso-ansi-language:IT\">), quindi i \u20ac20 miliardi\/anno hanno principalmente\naumentato il business del cancro.<o:p><\/o:p><\/span><\/p><p class=\"MsoNormal\" style=\"margin-bottom:0in;text-align:justify;text-indent:\n22.5pt;line-height:normal\"><span style=\"font-family:&quot;Times New Roman&quot;,serif;\ncolor:black;mso-themecolor:text1;mso-ansi-language:IT\">&nbsp;<\/span><\/p><p class=\"MsoNormal\" style=\"margin-bottom:0in;text-align:justify;text-indent:\n22.5pt;line-height:normal\"><span style=\"font-family:&quot;Times New Roman&quot;,serif;\nmso-ansi-language:IT\">Nel dialogo il RAGIONEVOLE spiega che \u00e8 comprensibile\nanche ad un bambino che chi gestisce i soldi delle nostre tasse sta buttando\nmiliardi di euro dalla finestra (o foraggiando il business del cancro) senza\nriuscire a ridurre la mortalit\u00e0 da cancro, mentre <b>ci sono persone in prima\nlinea che danno anima e corpo, lavorano gratuitamente, ed alcuni danno anche la\nloro vita <\/b>(come i medici, infermieri, forze dell\u2019ordine, e gli addetti al\nservizio pubblico che sono morti di COVID-19 per salvare gli altri), <b>pur\nsenza risorse, per alleviare le sofferenze e la mortalit\u00e0 da cancro.<\/b><span style=\"color:black;mso-themecolor:text1\"><o:p><\/o:p><\/span><\/span><\/p><p class=\"MsoNormal\" style=\"margin-bottom:0in;text-align:justify;text-indent:\n22.5pt;line-height:normal\"><span style=\"font-family:&quot;Times New Roman&quot;,serif;\ncolor:black;mso-themecolor:text1;mso-ansi-language:IT\">&nbsp;<\/span><\/p><p class=\"MsoNormal\" style=\"margin-bottom:0in;text-align:justify;text-indent:\n22.5pt;line-height:normal\"><b><span style=\"font-family:&quot;Times New Roman&quot;,serif;\ncolor:black;mso-themecolor:text1;mso-ansi-language:IT\">Non possiamo cambiare la\nstoria<\/span><\/b><span style=\"font-family:&quot;Times New Roman&quot;,serif;color:black;\nmso-themecolor:text1;mso-ansi-language:IT\"> che ha soppresso la mia invenzione\n3D-CBS causando la perdita inutile, negli ultimi 20 anni, di oltre 20 milioni\ndi vite e oltre 10.000 miliardi di dollari che avrebbero potuto essere\nrisparmiati, <b>ma possiamo cambiare il futuro. Se i giornalisti investigativi\ncreano un DIALOGO intervistando il sottoscritto e gli scienziati che non sono\nd&#8217;accordo con i miei calcoli<\/b> e la mia rivendicazione che la mia invenzione\n3D-CBS \u00e8 in grado di salvare 260 vite all&#8217;anno per macchina, se abbinata con un\ntrattamento del cancro di successo esistente, e implementando il mio piano\nstrategico di quattro pagine (<\/span><b><span style=\"font-family:&quot;Times New Roman&quot;,serif;\ncolor:blue;mso-ansi-language:IT\">https:\/\/bit.ly\/<\/span><\/b><span lang=\"EN-US\"><a href=\"https:\/\/drive.google.com\/file\/d\/1HDCFvFnq5P8apbdcNWkmYjiJ83bEAyed\/view?usp=sharing\"><b><span lang=\"IT\" style=\"font-family:&quot;Times New Roman&quot;,serif;mso-ansi-language:IT\">2V516AN<\/span><\/b><\/a><\/span><span style=\"font-family:&quot;Times New Roman&quot;,serif;color:black;mso-themecolor:text1;\nmso-ansi-language:IT\">), potremmo salvare oltre 100 milioni di vite e\nrisparmiare oltre 27.000 miliardi di dollari nei prossimi 30 anni nel mondo.<o:p><\/o:p><\/span><\/p><p class=\"MsoNormal\" style=\"margin-bottom:0in;text-align:justify;text-indent:\n22.5pt;line-height:normal\"><span style=\"font-family:&quot;Times New Roman&quot;,serif;\ncolor:black;mso-themecolor:text1;mso-ansi-language:IT\">&nbsp;<\/span><\/p><p class=\"MsoNormal\" style=\"margin-bottom:0in;text-align:justify;text-indent:\n22.5pt;line-height:normal\"><span style=\"font-family:&quot;Times New Roman&quot;,serif;\ncolor:black;mso-themecolor:text1;mso-ansi-language:IT\">Sembra tuttavia che ci\nsia un segno di un\u2019apertura al dialogo perch\u00e9 il <\/span><span style=\"font-family:\n&quot;Times New Roman&quot;,serif;mso-ansi-language:IT\">giorno del mio compleanno, 22\nluglio \u00e8 stato approvato l\u2019abstract di 300-parole del progetto 3D-CBS (3-D\nComplete Body Screening), presentato alla conferenza internazionale TBPET (Total\nBody PET). Questo abstract in 5 giorni con la sponsorizzazione di $1\/giorno su\nFacebook ha raggiunto oltre 100.000 persone e ha ricevuto 2.400 \u201cMi piace\u201d (<\/span><span style=\"font-family:&quot;Times New Roman&quot;,serif;mso-fareast-font-family:&quot;Times New Roman&quot;;\ncolor:#050505;mso-ansi-language:IT\">https:\/\/bit.ly\/<\/span><span lang=\"EN-US\"><a href=\"https:\/\/www.facebook.com\/permalink.php?story_fbid=4256984907670746&amp;id=114803041888974\"><span lang=\"IT\" style=\"font-family:&quot;Times New Roman&quot;,serif;mso-fareast-font-family:\n&quot;Times New Roman&quot;;mso-ansi-language:IT\">2Wchq3i<\/span><\/a><\/span><span style=\"font-family:&quot;Times New Roman&quot;,serif;mso-ansi-language:IT\">). <o:p><\/o:p><\/span><\/p><p class=\"MsoNormal\" style=\"margin-bottom:0in;text-align:justify;text-indent:\n22.5pt;line-height:normal\"><span style=\"font-family:&quot;Times New Roman&quot;,serif;\nmso-ansi-language:IT\">&nbsp;<\/span><\/p><p class=\"MsoNormal\" style=\"margin-bottom: 0in; text-align: justify; text-indent: 22.5pt; line-height: normal; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\"><b><span style=\"font-size:14.0pt;\nfont-family:&quot;Times New Roman&quot;,serif;color:#0070C0;mso-ansi-language:IT\">Sommario\narticolo sottoposto alla Conferenza TBPET (Total Body PET)<o:p><\/o:p><\/span><\/b><\/p><p class=\"MsoNormal\" style=\"margin-bottom: 0in; text-align: justify; text-indent: 22.5pt; line-height: normal; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\"><b><span style=\"font-family:&quot;Times New Roman&quot;,serif;\ncolor:#050505;mso-ansi-language:IT\">&nbsp;<\/span><\/b><\/p><p class=\"MsoNormal\" align=\"center\" style=\"margin-bottom: 0in; text-align: center; line-height: normal; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\"><b><span style=\"font-family:&quot;Times New Roman&quot;,serif;\ncolor:#050505;mso-ansi-language:IT\">Titolo<o:p><\/o:p><\/span><\/b><\/p><p class=\"MsoNormal\" align=\"center\" style=\"margin-bottom: 0in; text-align: center; line-height: normal; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\"><b><span style=\"font-size:12.0pt;\nfont-family:&quot;Times New Roman&quot;,serif;color:#050505;mso-ansi-language:IT\">Invenzione\nrivoluzionaria nell\u2019effettuare diagnosi basate sull\u2019andamento <br>\ndelle anomalie dei processi biologici calcolate dal CAD in base a ripetuti test\n<br>\ndi screening total-body sul 3D-CBS per salvare milioni di vite e miliardi di\ndollari<o:p><\/o:p><\/span><\/b><\/p><p class=\"MsoNormal\" align=\"center\" style=\"margin-bottom: 0in; text-align: center; line-height: normal; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\"><b><span style=\"font-family:&quot;Times New Roman&quot;,serif;\ncolor:#050505;mso-ansi-language:IT\">&nbsp;<\/span><\/b><\/p><p class=\"MsoNormal\" align=\"center\" style=\"margin-top:0in;margin-right:2.9pt;\nmargin-bottom:0in;margin-left:0in;text-align:center;line-height:normal\"><i><span lang=\"EN-US\" style=\"font-family:&quot;Times New Roman&quot;,serif\">Dario\nB.<span style=\"color: black; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\"> Crosetto &#8211; Crosetto Foundation\nfor the Reduction of Cancer Deaths &#8211; 900 Hideaway Pl. <\/span><\/span><\/i><i><span style=\"font-family: &quot;Times New Roman&quot;, serif; color: black; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\">DeSoto, TX \u2013 USA<b>.<\/b><\/span><\/i><b><span style=\"font-family:&quot;Times New Roman&quot;,serif;color:#050505;mso-ansi-language:\nIT\"><o:p><\/o:p><\/span><\/b><\/p><p class=\"MsoNormal\" align=\"center\" style=\"margin-top:0in;margin-right:2.9pt;\nmargin-bottom:0in;margin-left:0in;text-align:center;line-height:normal\"><b><span style=\"font-family:&quot;Times New Roman&quot;,serif;color:#050505;mso-ansi-language:\nIT\">&nbsp;<\/span><\/b><\/p><p class=\"MsoNormal\" align=\"center\" style=\"margin-bottom: 0in; text-align: center; line-height: normal; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\"><b><span style=\"font-family:&quot;Times New Roman&quot;,serif;\ncolor:#050505;mso-ansi-language:IT\">Abstract<o:p><\/o:p><\/span><\/b><\/p><p class=\"MsoNormal\" style=\"margin: 0in 0in 0in 40.5pt; text-align: justify; text-indent: -40.5pt; line-height: normal; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\"><b><span style=\"font-family:&quot;Times New Roman&quot;,serif;\ncolor:#050505;mso-ansi-language:IT\">Antefatti:<\/span><\/b><span style=\"font-family:&quot;Times New Roman&quot;,serif;color:#050505;mso-ansi-language:\nIT\"> 3D-CBS (3D Complete Body Screening) [1] il primo vero cambiamento\nparadigmatico nell&#8217;imaging biomedico inventato 21 anni fa, confermato da\nrisultati misurati da terzi su una copia del 3D-CBS in grado di rilevare in\nmodo sicuro cluster (tumori) di 100 cellule invece di un miliardo di cellule (1\ncm3).<o:p><\/o:p><\/span><\/p><p class=\"MsoNormal\" style=\"margin: 0in 0in 0in 40.5pt; text-align: justify; text-indent: -40.5pt; line-height: normal; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\"><span style=\"font-family:&quot;Times New Roman&quot;,serif;color:#050505;\nmso-ansi-language:IT\">&nbsp;<\/span><\/p><p class=\"MsoNormal\" style=\"margin: 0in 0in 0in 40.5pt; text-align: justify; text-indent: -40.5pt; line-height: normal; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\"><b><span style=\"font-family:&quot;Times New Roman&quot;,serif;\ncolor:#050505;mso-ansi-language:IT\">Materiali e metodi:<\/span><\/b><span style=\"font-family:&quot;Times New Roman&quot;,serif;color:#050505;mso-ansi-language:\nIT\"> Un\u2019apparecchiatura 3D-CBS con componenti che costano meno di\n$2.000.000\/apparecchiatura, con un FOV da 157cm in grado di rilevare dai\nmarcatori tumorali tutte le possibili coppie di fotoni da 511keV al minor costo\nper coppia valida acquisita, con un test di screening che costa $200 per 2\nminuti ed un esame clinico da $1.200 per 15 minuti. In due turni di 8 ore, il\n3D-CBS pu\u00f2 eseguire in sicurezza 360&#215;2 minuti tests e 8&#215;15 minuti esami clinici\n[2]. Per effettuate ci\u00f2, si stima che siano necessari 48 professionisti\/giorno:\n8 amministrazione, 4 logistica, 8 infermieri, 8 tecnici e 20 medici (con uno\nstipendio annuale di $400.000), ogni medico pu\u00f2 leggere 16-20 test di\nscreening\/giorno per 22 minuti ciascuno e 1-esame clinico per 68 minuti. Le\npersone devono eseguire diversi test di screening sulla stessa apparecchiatura,\nutilizzando lo stesso protocollo e la stessa dose di radiazione. Per evitare\nfalsi positivi, la diagnosi non si baser\u00e0 su un singolo test di screening ma\nsul Computer-Aided Diagnosis (CAD) che calcola l&#8217;andamento delle anomalie in\ndiversi test di screening e l&#8217;esperienza del radiologo. Il primo test di\nscreening fornisce una base. Gli screening successivi rivelano punti caldi unici\nche mostrano un aumento dell&#8217;attivit\u00e0\/dimensione di un processo biologico\nanomalo che richiede un&#8217;indagine pi\u00f9 approfondita (esame clinico di 15 minuti).\nI tests di screening prima\/dopo l&#8217;intervento chirurgico rilevano se sono\nrimaste cellule tumorali e monitorano le recidive in una fase precoce,\naltamente curabile.<o:p><\/o:p><\/span><\/p><p class=\"MsoNormal\" style=\"margin: 0in 0in 0in 40.5pt; text-align: justify; text-indent: -40.5pt; line-height: normal; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\"><span style=\"font-family:&quot;Times New Roman&quot;,serif;color:#050505;\nmso-ansi-language:IT\">&nbsp;<\/span><\/p><p class=\"MsoNormal\" style=\"margin: 0in 0in 0in 40.5pt; text-align: justify; text-indent: -40.5pt; line-height: normal; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\"><b><span style=\"font-family:&quot;Times New Roman&quot;,serif;\ncolor:#050505;mso-ansi-language:IT\">Risultati: Con l<\/span><\/b><span style=\"font-family:&quot;Times New Roman&quot;,serif;color:#050505;mso-ansi-language:\nIT\">o screening di 90.000\/test\/anno\/apparecchiatura, 57 miliardi di test\/30\nanni su 57.000 apparecchiature 3D-CBS costruite gradualmente in 30 anni, si\npossono salvare oltre 100.000.000 di vite e oltre 27.000 miliardi di dollari\n[3] (Figura-1).<o:p><\/o:p><\/span><\/p><p class=\"MsoNormal\" style=\"margin: 0in 0in 0in 40.5pt; text-align: justify; text-indent: -40.5pt; line-height: normal; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\"><span style=\"font-family:&quot;Times New Roman&quot;,serif;color:#050505;\nmso-ansi-language:IT\">&nbsp;<\/span><\/p><p class=\"MsoNormal\" style=\"margin: 0in 0in 0in 40.5pt; text-align: justify; text-indent: -40.5pt; line-height: normal; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\"><b><span style=\"font-family:&quot;Times New Roman&quot;,serif;\ncolor:#050505;mso-ansi-language:IT\">Conclusioni:<\/span><\/b><span style=\"font-family:&quot;Times New Roman&quot;,serif;color:#050505;mso-ansi-language:\nIT\"> Poich\u00e9 la diagnosi precoce del cancro pu\u00f2 salvare fino al 98% di vite, un\ntest sperimentale su una popolazione campione di questo approccio basato sul\nCAD che calcola l&#8217;andamento delle anomalie in diversi test di screening sul\n3D-CBS e l&#8217;esperienza del radiologo dimostrer\u00e0 definitivamente che possiamo\nsalvare centinaia di milioni di vite e migliaia di miliardi di dollari.<o:p><\/o:p><\/span><\/p><p class=\"MsoNormal\" style=\"margin: 0in 0in 0in 40.5pt; text-align: justify; text-indent: -40.5pt; line-height: normal; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\"><span style=\"font-family:&quot;Times New Roman&quot;,serif;color:#050505;\nmso-ansi-language:IT\">&nbsp;<\/span><\/p><p class=\"MsoNormal\" style=\"margin-bottom: 0in; text-align: justify; line-height: normal; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\"><span style=\"font-family:&quot;Times New Roman&quot;,serif;\ncolor:#050505;mso-ansi-language:IT\">[1]-Crosetto, D.\nLibro-tecnico-scientifico-2000-ISBN-0-9702897-0-7- <\/span><span lang=\"EN-US\" style=\"color:black;mso-color-alt:windowtext\"><a href=\"https:\/\/drive.google.com\/file\/d\/0BxWfo2ViJ6r5WVFVWnJteENqMWc\/view?usp=sharing\"><span lang=\"IT\" style=\"font-family:&quot;Times New Roman&quot;,serif;background:#EEEEEE;\nmso-ansi-language:IT\">goo.gl\/ggGGwF<\/span><\/a><\/span><span style=\"font-family:\n&quot;Times New Roman&quot;,serif;color:#050505;mso-ansi-language:IT\"><o:p><\/o:p><\/span><\/p><p class=\"MsoNormal\" style=\"margin-bottom: 0in; text-align: justify; line-height: normal; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\"><span style=\"font-family:&quot;Times New Roman&quot;,serif;\ncolor:#050505;mso-ansi-language:IT\">[2]-Crosetto, D. Articolo-2020- <\/span><span style=\"font-family:&quot;Times New Roman&quot;,serif;color:black;mso-color-alt:windowtext;\nmso-ansi-language:IT\">https:\/\/<\/span><span lang=\"EN-US\" style=\"color:black;\nmso-color-alt:windowtext\"><a href=\"https:\/\/drive.google.com\/file\/d\/1yeC8p1lsmZxagarlU8OM582frwtiyOq3\/view?usp=sharing\" target=\"_blank\"><span lang=\"IT\" style=\"font-family:&quot;Times New Roman&quot;,serif;\nmso-ansi-language:IT\">bit.ly\/2NFkJbK<\/span><\/a><\/span><span style=\"font-family:\n&quot;Times New Roman&quot;,serif;color:#050505;mso-ansi-language:IT\"><o:p><\/o:p><\/span><\/p><p class=\"MsoNormal\" style=\"margin-bottom: 0in; text-align: justify; line-height: normal; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\"><span style=\"font-family:&quot;Times New Roman&quot;,serif;\ncolor:#050505;mso-ansi-language:IT\">[3]-Crosetto, D.\nCalcoli\/Rivendicazioni-2021- <\/span><span style=\"font-family:&quot;Times New Roman&quot;,serif;\nmso-fareast-font-family:Calibri;color:black;mso-color-alt:windowtext;\nmso-ansi-language:IT\">https:\/\/bit.ly\/<\/span><span lang=\"EN-US\" style=\"color:black;\nmso-color-alt:windowtext\"><a href=\"https:\/\/drive.google.com\/file\/d\/16eY9vkvCmXzMMrdGPZf2jb0jW9gDYDca\/view?usp=sharing\"><span lang=\"IT\" style=\"font-family:&quot;Times New Roman&quot;,serif;mso-fareast-font-family:\nCalibri;mso-ansi-language:IT\">3gTXdHl<\/span><\/a><\/span><span style=\"font-family:\n&quot;Times New Roman&quot;,serif;color:#050505;mso-ansi-language:IT\"><o:p><\/o:p><\/span><\/p><p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal\"><span style=\"font-family:&quot;Times New Roman&quot;,serif;mso-ansi-language:IT\">&nbsp;<\/span><\/p><p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal\"><span style=\"font-family:&quot;Times New Roman&quot;,serif;mso-ansi-language:IT\">Interrogazione\npubblicata sulla pagina dell\u2019On. Panza:<o:p><\/o:p><\/span><\/p><p>\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n<\/p><p class=\"MsoNormal\" style=\"margin-bottom:0in;line-height:normal\"><span style=\"font-family:&quot;Times New Roman&quot;,serif;color:black;mso-themecolor:text1;\nmso-ansi-language:IT\">(<\/span><span lang=\"EN-US\"><a href=\"https:\/\/www.europarl.europa.eu\/doceo\/document\/E-9-2021-003244_IT.html\"><span lang=\"IT\" style=\"font-family:&quot;Times New Roman&quot;,serif;mso-ansi-language:IT\">https:\/\/www.europarl.europa.eu\/doceo\/document\/E-9-2021-003244_IT.html<\/span><\/a><\/span><span style=\"font-family:&quot;Times New Roman&quot;,serif;color:black;mso-themecolor:text1;\nmso-ansi-language:IT\">)<\/span><span style=\"font-family:&quot;Times New Roman&quot;,serif;\nmso-ansi-language:IT\"><o:p><\/o:p><\/span><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-d518cc9 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"d518cc9\" data-element_type=\"section\" data-e-type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-407b611\" data-id=\"407b611\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-5776678 elementor-widget elementor-widget-image\" data-id=\"5776678\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"image.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<img fetchpriority=\"high\" decoding=\"async\" width=\"1489\" height=\"2105\" src=\"https:\/\/crosettofoundation.org\/wp-content\/uploads\/2021\/08\/Il-previdente_36-corretto_Page_01.jpg\" class=\"attachment-full size-full wp-image-116\" alt=\"\" srcset=\"https:\/\/crosettofoundation.org\/wp-content\/uploads\/2021\/08\/Il-previdente_36-corretto_Page_01.jpg 1489w, https:\/\/crosettofoundation.org\/wp-content\/uploads\/2021\/08\/Il-previdente_36-corretto_Page_01-600x848.jpg 600w, https:\/\/crosettofoundation.org\/wp-content\/uploads\/2021\/08\/Il-previdente_36-corretto_Page_01-212x300.jpg 212w, https:\/\/crosettofoundation.org\/wp-content\/uploads\/2021\/08\/Il-previdente_36-corretto_Page_01-724x1024.jpg 724w, https:\/\/crosettofoundation.org\/wp-content\/uploads\/2021\/08\/Il-previdente_36-corretto_Page_01-768x1086.jpg 768w, https:\/\/crosettofoundation.org\/wp-content\/uploads\/2021\/08\/Il-previdente_36-corretto_Page_01-1087x1536.jpg 1087w, https:\/\/crosettofoundation.org\/wp-content\/uploads\/2021\/08\/Il-previdente_36-corretto_Page_01-1449x2048.jpg 1449w\" sizes=\"(max-width: 1489px) 100vw, 1489px\" \/>\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-a12ebdf elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"a12ebdf\" data-element_type=\"section\" data-e-type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-4464fe6\" data-id=\"4464fe6\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-8e1844d elementor-widget elementor-widget-image\" data-id=\"8e1844d\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"image.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<img decoding=\"async\" width=\"1654\" height=\"2339\" src=\"https:\/\/crosettofoundation.org\/wp-content\/uploads\/2021\/08\/Articolo-Intervista-3D-CBS-Crosetto-Il-previdente_36-corretto_Page_1.jpg\" class=\"attachment-full size-full wp-image-118\" alt=\"\" srcset=\"https:\/\/crosettofoundation.org\/wp-content\/uploads\/2021\/08\/Articolo-Intervista-3D-CBS-Crosetto-Il-previdente_36-corretto_Page_1.jpg 1654w, https:\/\/crosettofoundation.org\/wp-content\/uploads\/2021\/08\/Articolo-Intervista-3D-CBS-Crosetto-Il-previdente_36-corretto_Page_1-600x848.jpg 600w, https:\/\/crosettofoundation.org\/wp-content\/uploads\/2021\/08\/Articolo-Intervista-3D-CBS-Crosetto-Il-previdente_36-corretto_Page_1-212x300.jpg 212w, https:\/\/crosettofoundation.org\/wp-content\/uploads\/2021\/08\/Articolo-Intervista-3D-CBS-Crosetto-Il-previdente_36-corretto_Page_1-724x1024.jpg 724w, https:\/\/crosettofoundation.org\/wp-content\/uploads\/2021\/08\/Articolo-Intervista-3D-CBS-Crosetto-Il-previdente_36-corretto_Page_1-768x1086.jpg 768w, https:\/\/crosettofoundation.org\/wp-content\/uploads\/2021\/08\/Articolo-Intervista-3D-CBS-Crosetto-Il-previdente_36-corretto_Page_1-1086x1536.jpg 1086w, https:\/\/crosettofoundation.org\/wp-content\/uploads\/2021\/08\/Articolo-Intervista-3D-CBS-Crosetto-Il-previdente_36-corretto_Page_1-1448x2048.jpg 1448w, https:\/\/crosettofoundation.org\/wp-content\/uploads\/2021\/08\/Articolo-Intervista-3D-CBS-Crosetto-Il-previdente_36-corretto_Page_1-1568x2217.jpg 1568w\" sizes=\"(max-width: 1654px) 100vw, 1654px\" \/>\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-96d9fcb elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"96d9fcb\" data-element_type=\"section\" data-e-type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-2d0a210\" data-id=\"2d0a210\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-cdc29ae elementor-widget elementor-widget-image\" data-id=\"cdc29ae\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"image.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<img decoding=\"async\" width=\"786\" height=\"1111\" src=\"https:\/\/crosettofoundation.org\/wp-content\/uploads\/2021\/08\/Articolo-Intervista-3D-CBS-Crosetto-Il-previdente_36-corretto_Page_2.jpg\" class=\"attachment-full size-full wp-image-120\" alt=\"\" srcset=\"https:\/\/crosettofoundation.org\/wp-content\/uploads\/2021\/08\/Articolo-Intervista-3D-CBS-Crosetto-Il-previdente_36-corretto_Page_2.jpg 786w, https:\/\/crosettofoundation.org\/wp-content\/uploads\/2021\/08\/Articolo-Intervista-3D-CBS-Crosetto-Il-previdente_36-corretto_Page_2-600x848.jpg 600w, https:\/\/crosettofoundation.org\/wp-content\/uploads\/2021\/08\/Articolo-Intervista-3D-CBS-Crosetto-Il-previdente_36-corretto_Page_2-212x300.jpg 212w, https:\/\/crosettofoundation.org\/wp-content\/uploads\/2021\/08\/Articolo-Intervista-3D-CBS-Crosetto-Il-previdente_36-corretto_Page_2-724x1024.jpg 724w, https:\/\/crosettofoundation.org\/wp-content\/uploads\/2021\/08\/Articolo-Intervista-3D-CBS-Crosetto-Il-previdente_36-corretto_Page_2-768x1086.jpg 768w\" sizes=\"(max-width: 786px) 100vw, 786px\" \/>\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-5a82c7b elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"5a82c7b\" data-element_type=\"section\" data-e-type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-b75f0cc\" data-id=\"b75f0cc\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-4467e75 elementor-widget elementor-widget-image\" data-id=\"4467e75\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"image.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"1654\" height=\"2339\" src=\"https:\/\/crosettofoundation.org\/wp-content\/uploads\/2021\/08\/Articolo-Intervista-3D-CBS-Crosetto-Il-previdente_36-corretto_Page_3.jpg\" class=\"attachment-full size-full wp-image-122\" alt=\"\" srcset=\"https:\/\/crosettofoundation.org\/wp-content\/uploads\/2021\/08\/Articolo-Intervista-3D-CBS-Crosetto-Il-previdente_36-corretto_Page_3.jpg 1654w, https:\/\/crosettofoundation.org\/wp-content\/uploads\/2021\/08\/Articolo-Intervista-3D-CBS-Crosetto-Il-previdente_36-corretto_Page_3-600x848.jpg 600w, https:\/\/crosettofoundation.org\/wp-content\/uploads\/2021\/08\/Articolo-Intervista-3D-CBS-Crosetto-Il-previdente_36-corretto_Page_3-212x300.jpg 212w, https:\/\/crosettofoundation.org\/wp-content\/uploads\/2021\/08\/Articolo-Intervista-3D-CBS-Crosetto-Il-previdente_36-corretto_Page_3-724x1024.jpg 724w, https:\/\/crosettofoundation.org\/wp-content\/uploads\/2021\/08\/Articolo-Intervista-3D-CBS-Crosetto-Il-previdente_36-corretto_Page_3-768x1086.jpg 768w, https:\/\/crosettofoundation.org\/wp-content\/uploads\/2021\/08\/Articolo-Intervista-3D-CBS-Crosetto-Il-previdente_36-corretto_Page_3-1086x1536.jpg 1086w, https:\/\/crosettofoundation.org\/wp-content\/uploads\/2021\/08\/Articolo-Intervista-3D-CBS-Crosetto-Il-previdente_36-corretto_Page_3-1448x2048.jpg 1448w, https:\/\/crosettofoundation.org\/wp-content\/uploads\/2021\/08\/Articolo-Intervista-3D-CBS-Crosetto-Il-previdente_36-corretto_Page_3-1568x2217.jpg 1568w\" sizes=\"(max-width: 1654px) 100vw, 1654px\" \/>\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-c6ab154 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"c6ab154\" data-element_type=\"section\" data-e-type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-94bbdc2\" data-id=\"94bbdc2\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-ee47b37 elementor-widget elementor-widget-image\" data-id=\"ee47b37\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"image.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"1489\" height=\"2105\" src=\"https:\/\/crosettofoundation.org\/wp-content\/uploads\/2021\/08\/Articolo-Intervista-3D-CBS-Crosetto-Il-previdente_36-corretto_Page_4.jpg\" class=\"attachment-full size-full wp-image-124\" alt=\"\" srcset=\"https:\/\/crosettofoundation.org\/wp-content\/uploads\/2021\/08\/Articolo-Intervista-3D-CBS-Crosetto-Il-previdente_36-corretto_Page_4.jpg 1489w, https:\/\/crosettofoundation.org\/wp-content\/uploads\/2021\/08\/Articolo-Intervista-3D-CBS-Crosetto-Il-previdente_36-corretto_Page_4-600x848.jpg 600w, https:\/\/crosettofoundation.org\/wp-content\/uploads\/2021\/08\/Articolo-Intervista-3D-CBS-Crosetto-Il-previdente_36-corretto_Page_4-212x300.jpg 212w, https:\/\/crosettofoundation.org\/wp-content\/uploads\/2021\/08\/Articolo-Intervista-3D-CBS-Crosetto-Il-previdente_36-corretto_Page_4-724x1024.jpg 724w, https:\/\/crosettofoundation.org\/wp-content\/uploads\/2021\/08\/Articolo-Intervista-3D-CBS-Crosetto-Il-previdente_36-corretto_Page_4-768x1086.jpg 768w, https:\/\/crosettofoundation.org\/wp-content\/uploads\/2021\/08\/Articolo-Intervista-3D-CBS-Crosetto-Il-previdente_36-corretto_Page_4-1087x1536.jpg 1087w, https:\/\/crosettofoundation.org\/wp-content\/uploads\/2021\/08\/Articolo-Intervista-3D-CBS-Crosetto-Il-previdente_36-corretto_Page_4-1449x2048.jpg 1449w\" sizes=\"(max-width: 1489px) 100vw, 1489px\" \/>\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-362d20a elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"362d20a\" data-element_type=\"section\" data-e-type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-30de7a2\" data-id=\"30de7a2\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-3ec4e87 elementor-widget elementor-widget-image\" data-id=\"3ec4e87\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"image.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"1654\" height=\"2339\" src=\"https:\/\/crosettofoundation.org\/wp-content\/uploads\/2021\/08\/Articolo-Intervista-3D-CBS-Crosetto-Il-previdente_36-corretto_Page_5.jpg\" class=\"attachment-full size-full wp-image-126\" alt=\"\" srcset=\"https:\/\/crosettofoundation.org\/wp-content\/uploads\/2021\/08\/Articolo-Intervista-3D-CBS-Crosetto-Il-previdente_36-corretto_Page_5.jpg 1654w, https:\/\/crosettofoundation.org\/wp-content\/uploads\/2021\/08\/Articolo-Intervista-3D-CBS-Crosetto-Il-previdente_36-corretto_Page_5-600x848.jpg 600w, https:\/\/crosettofoundation.org\/wp-content\/uploads\/2021\/08\/Articolo-Intervista-3D-CBS-Crosetto-Il-previdente_36-corretto_Page_5-212x300.jpg 212w, https:\/\/crosettofoundation.org\/wp-content\/uploads\/2021\/08\/Articolo-Intervista-3D-CBS-Crosetto-Il-previdente_36-corretto_Page_5-724x1024.jpg 724w, https:\/\/crosettofoundation.org\/wp-content\/uploads\/2021\/08\/Articolo-Intervista-3D-CBS-Crosetto-Il-previdente_36-corretto_Page_5-768x1086.jpg 768w, https:\/\/crosettofoundation.org\/wp-content\/uploads\/2021\/08\/Articolo-Intervista-3D-CBS-Crosetto-Il-previdente_36-corretto_Page_5-1086x1536.jpg 1086w, https:\/\/crosettofoundation.org\/wp-content\/uploads\/2021\/08\/Articolo-Intervista-3D-CBS-Crosetto-Il-previdente_36-corretto_Page_5-1448x2048.jpg 1448w, https:\/\/crosettofoundation.org\/wp-content\/uploads\/2021\/08\/Articolo-Intervista-3D-CBS-Crosetto-Il-previdente_36-corretto_Page_5-1568x2217.jpg 1568w\" sizes=\"(max-width: 1654px) 100vw, 1654px\" \/>\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-8e6f3b4 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"8e6f3b4\" data-element_type=\"section\" data-e-type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-33a4dc2\" data-id=\"33a4dc2\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-3dd5830 elementor-widget elementor-widget-image\" data-id=\"3dd5830\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"image.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"1654\" height=\"2339\" src=\"https:\/\/crosettofoundation.org\/wp-content\/uploads\/2021\/08\/Articolo-Intervista-3D-CBS-Crosetto-Il-previdente_36-corretto_Page_6.jpg\" class=\"attachment-full size-full wp-image-128\" alt=\"\" srcset=\"https:\/\/crosettofoundation.org\/wp-content\/uploads\/2021\/08\/Articolo-Intervista-3D-CBS-Crosetto-Il-previdente_36-corretto_Page_6.jpg 1654w, https:\/\/crosettofoundation.org\/wp-content\/uploads\/2021\/08\/Articolo-Intervista-3D-CBS-Crosetto-Il-previdente_36-corretto_Page_6-600x848.jpg 600w, https:\/\/crosettofoundation.org\/wp-content\/uploads\/2021\/08\/Articolo-Intervista-3D-CBS-Crosetto-Il-previdente_36-corretto_Page_6-212x300.jpg 212w, https:\/\/crosettofoundation.org\/wp-content\/uploads\/2021\/08\/Articolo-Intervista-3D-CBS-Crosetto-Il-previdente_36-corretto_Page_6-724x1024.jpg 724w, https:\/\/crosettofoundation.org\/wp-content\/uploads\/2021\/08\/Articolo-Intervista-3D-CBS-Crosetto-Il-previdente_36-corretto_Page_6-768x1086.jpg 768w, https:\/\/crosettofoundation.org\/wp-content\/uploads\/2021\/08\/Articolo-Intervista-3D-CBS-Crosetto-Il-previdente_36-corretto_Page_6-1086x1536.jpg 1086w, https:\/\/crosettofoundation.org\/wp-content\/uploads\/2021\/08\/Articolo-Intervista-3D-CBS-Crosetto-Il-previdente_36-corretto_Page_6-1448x2048.jpg 1448w, https:\/\/crosettofoundation.org\/wp-content\/uploads\/2021\/08\/Articolo-Intervista-3D-CBS-Crosetto-Il-previdente_36-corretto_Page_6-1568x2217.jpg 1568w\" sizes=\"(max-width: 1654px) 100vw, 1654px\" \/>\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"<p>I 20 miliardi annuali spesi per il cancro in Italia non devono creare una competizione tra i ricercatori ma un\u2019unione nel discutere pubblicamente i piani strategici che possono sconfiggere il [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":197,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"video","meta":{"_acf_changed":false,"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":"","_links_to":"","_links_to_target":""},"categories":[160,12],"tags":[],"class_list":["post-271","post","type-post","status-publish","format-video","has-post-thumbnail","hentry","category-dialogo-con-le-assoc-cancro","category-new-template-post-it","post_format-post-format-video"],"acf":[],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/crosettofoundation.org\/it\/wp-json\/wp\/v2\/posts\/271","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/crosettofoundation.org\/it\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/crosettofoundation.org\/it\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/crosettofoundation.org\/it\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/crosettofoundation.org\/it\/wp-json\/wp\/v2\/comments?post=271"}],"version-history":[{"count":13,"href":"https:\/\/crosettofoundation.org\/it\/wp-json\/wp\/v2\/posts\/271\/revisions"}],"predecessor-version":[{"id":17122,"href":"https:\/\/crosettofoundation.org\/it\/wp-json\/wp\/v2\/posts\/271\/revisions\/17122"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/crosettofoundation.org\/it\/wp-json\/wp\/v2\/media\/197"}],"wp:attachment":[{"href":"https:\/\/crosettofoundation.org\/it\/wp-json\/wp\/v2\/media?parent=271"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/crosettofoundation.org\/it\/wp-json\/wp\/v2\/categories?post=271"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/crosettofoundation.org\/it\/wp-json\/wp\/v2\/tags?post=271"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}